Selected Publications

  1. Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevigné A, Ectors F, Plenevaux A, Pirotte B, Beckers A: GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G s and G q/11. Nature communications 2020, 11(1):1-16.
  2. Ahlstedt J, Johansson E, Sydoff M, Karlsson H, Thordarsson E, Gram M, Eriksson O: Non-invasive imaging methodologies for assessment of radiation damage to bone marrow and kidneys from peptide receptor radionuclide therapy. Neuroendocrinology 2020.
  3. Ahmed H, Wallimann R, Haider A, Hosseini V, Gruber S, Robledo M, Nguyen TA, Herde AM, Iten I, Keller C: Preclinical development of 18F-OF-NB1 for imaging GluN2B-containing N-methyl-D-aspartate receptors and its utility as a biomarker for amyotrophic lateral sclerosis. Journal of Nuclear Medicine 2020:jnumed. 120.246785.
  4. Akerele MI, Zein S, Pandya S, Nikolopoulou A, Gauthier SA, Raj A, Henchcliffe C, Mozley PD, Karakatsanis NA, Gupta A: Feasibility of Population-Based Input Function for Kinetic Modeling of [11C]-DPA-713. 2020.
  5. Albrecht J, Exner S, Groetzinger C, Prasad S, Konietschke F, Beindorff N, Kuehl AA, Prasad V, Brenner W, Koziolek EJ: Multimodal imaging of two-cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an orthotopic neuroendocrine xenograft tumor mouse model. Journal of Nuclear Medicine 2020:jnumed. 120.250274.
  6. Alia-Klein N, Preston-Campbell RN, Kim SW, Pareto D, Logan J, Wang G-J, Moeller SJ, Fowler JS, Biegon A: Human Cognitive Ability Is Modulated by Aromatase Availability in the Brain in a Sex-Specific Manner. Frontiers in Neuroscience 2020, 14.
  7. Ando T, Kemp B, Warnock G, Sekine T, Kaushik S, Wiesinger F, Delso G: Zero Echo Time MRAC on FDG-PET/MR Maintains Diagnostic Accuracy for Alzheimer’s Disease; A Simulation Study Combining ADNI-Data. Frontiers in Neuroscience 2020, 14.
  8. Ando T, Sekine T, Murai Y, Orita E, Takagi R, Amano Y, Iwata K, Nakaza M, Ogawa M, Obara M: Multiparametric flow analysis using four-dimensional flow magnetic resonance imaging can detect cerebral hemodynamic impairment in patients with internal carotid artery stenosis. Neuroradiology 2020.
  9. Andrews JP, Portal C, Walton T, Macaskill MG, Hadoke PW, Alcaide Corral C, Lucatelli C, Wilson S, Wilson I, MacNaught G: Non-invasive in vivo imaging of acute thrombosis: development of a novel factor XIIIa radiotracer. European Heart Journal-Cardiovascular Imaging 2020, 21(6):673-682.
  10. Aohara K, Minatani S, Kimura H, Takeuchi J, Takeda A, Kawabe J, Wada Y, Mawatari A, Watanabe Y, Shimada H: Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease. Neurology and Clinical Neuroscience 2020, 8(2):61-67.
  11. Aoyama M, Takizawa H, Otani T, Inoue S, Kawakita N, Tsuboi M, Bando Y, Uehara H, Kondo K, Tangoku A: Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT. Oncology Reports 2020, 44(4):1709-1716.
  12. Arakawa R, Takano A, Stenkrona P, Stepanov V, Nag S, Jahan M, Grybäck P, Bolin M, Chen L, Zhang L: PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18 F] PF-06684511. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
  13. Ardaya M, Joya A, Padro D, Plaza-García S, Gómez-Vallejo V, Sánchez M, Garbizu M, Cossío U, Matute C, Cavaliere F: In vivo PET imaging of gliogenesis after cerebral ischemia in rats. Frontiers in Neuroscience 2020, 14.
  14. Auditore L, Amato E, Boughdad S, Meyer M, Testart N, Cicone F, Beigelman-Aubry C, Prior JO, Schaefer N, Gnesin S: Monte Carlo 90Y PET/CT dosimetry of unexpected focal radiation-induced lung damage after hepatic radioembolisation. Physics in Medicine & Biology 2020, 65(23):235014.
  15. Azevedo PN, Zanirati G, Venturin GT, Schu GG, Durán–Carabali LE, Odorcyk FK, Soares AV, de Oliveira Laguna G, Netto CA, Zimmer ER: Long-term changes in metabolic brain network drive memory impairments in rats following neonatal hypoxia-ischemia. Neurobiology of Learning and Memory 2020:107207.
  16. Babin V, Tournier BB, Davis A, Dubost E, Pigrée G, Lohier J-F, Reboul V, Cailly T, Bouillon J-P, Millet P: Design of iodinated radioligands for SPECT imaging of central human 5-HT4R using a ligand lipophilicity efficiency approach. Bioorganic Chemistry 2020, 96:103582.
  17. Backhaus P, Büther F, Wachsmuth L, Frohwein L, Buchholz R, Karst U, Schäfers K, Hermann S, Schäfers M, Faber C: Toward precise arterial input functions derived from DCE‐MRI through a novel extracorporeal circulation approach in mice. Magnetic Resonance in Medicine 2020.
  18. Bai P, Bai S, Placzek MS, Lu X, Fiedler SA, Ntaganda B, Wey H-Y, Wang C: A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging. Molecules 2020, 25(5):1018.
  19. Bai P, Lan Y, Wang H, Chen Z, Fiedler S, Striar R, Lu X, Wang C: Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins. Frontiers in molecular biosciences 2020, 7:198.
  20. Bai P, Lu X, Lan Y, Chen Z, Patnaik D, Fiedler S, Striar R, Haggarty SJ, Wang C: Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins. Nuclear Medicine and Biology 2020.
  21. Balcerzyk M, De-Miguel M, Guerrero C, Fernandez B: Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography. Cells 2020, 9(9):2084.
  22. Baraibar I, Roman M, Rodríguez-Remírez M, López I, Vilalta A, Guruceaga E, Ecay M, Collantes M, Lozano T, Alignani D: Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells. Cancers 2020, 12(11):3169.
  23. Barrett HE, Meester EJ, van Gaalen K, van der Heiden K, Krenning BJ, Beekman FJ, de Blois E, de Swart J, Verhagen H, Maina T: Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
  24. Barron AM, Ji B, Fujinaga M, Zhang M-R, Suhara T, Sahara N, Aoki I, Tsukada H, Higuchi M: In vivo PET imaging of mitochondrial abnormalities in a mouse model of tauopathy. Neurobiology of Aging 2020.
  25. Bascuñana P, Brackhan M, Leiter I, Keller H, Jahreis I, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: Divergent metabolic substrate utilization in brain during epileptogenesis precedes chronic hypometabolism. Journal of Cerebral Blood Flow & Metabolism 2020, 40(1):204-213.
  26. Bascuñana P, Hess A, Borchert T, Wang Y, Wollert KC, Bengel FM, Thackeray JT: 11C-Methionine PET Identifies Astroglia Involvement in Heart–Brain Inflammation Networking After Acute Myocardial Infarction. Journal of Nuclear Medicine 2020, 61(7):977-980.
  27. Bascuñana P, Wolf BJ, Jahreis I, Brackhan M, García-García L, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: 99mTc-HMPAO SPECT imaging reveals brain hypoperfusion during status epilepticus. 2020.
  28. Bashir A, Binderup T, Vestergaard MB, Broholm H, Marner L, Ziebell M, Fugleholm K, Kjaer A, Law I: In vivo imaging of cell proliferation in meningioma using 3′-deoxy-3′-[18 F] fluorothymidine PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-14.
  29. Bashir A, Vestergaard MB, Binderup T, Broholm H, Marner L, Ziebell M, Fugleholm K, Mathiesen T, Kjær A, Law I: Pharmacokinetic analysis of [68 Ga] Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-12.
  30. Bastin C, Bahri MA, Meyer F, Manard M, Delhaye E, Plenevaux A, Becker G, Seret A, Mella C, Giacomelli F: In vivo imaging of synaptic loss in Alzheimer’s disease with [18F] UCB-H positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(2):390-402.
  31. Bauer EK, Stoffels G, Blau T, Reifenberger G, Felsberg J, Werner JM, Lohmann P, Rosen J, Ceccon G, Tscherpel C: Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18 F]-fluoroethyl)-l-tyrosine PET. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
  32. Bauer M, Bamminger K, Pichler V, Weber M, Binder S, Maier‐Salamon A, Tahir A, Jäger W, Haslacher H, Tournier N: Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clinical Pharmacology & Therapeutics 2020.
  33. Becker G, Dammicco S, Bahri MA, Salmon E: The Rise of Synaptic Density PET Imaging. Molecules 2020, 25(10):2303.
  34. Beinat C, Patel CB, Haywood T, Shen B, Naya L, Gandhi H, Holley D, Khalighi M, Iagaru A, Davidzon G: Human biodistribution and radiation dosimetry of [18 F] DASA-23, a PET probe targeting pyruvate kinase M2. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-8.
  35. Belderbos S, González-Gómez MA, Cleeren F, Wouters J, Piñeiro Y, Deroose CM, Coosemans A, Gsell W, Bormans G, Rivas J: Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe 3 O 4@ Al (OH) 3 nanoparticles: Comparison of nanoparticle and nanoparticle-labeled stem cell distribution. EJNMMI research 2020, 10(1):1-13.
  36. Bellés L, Dimiziani A, Tsartsalis S, Millet P, Herrmann FR, Ginovart N: Dopamine D2/3 receptor availabilities and evoked dopamine release in striatum differentially predict impulsivity and novelty preference in Roman high-and low-avoidance rats. International Journal of Neuropsychopharmacology 2020.
  37. Bengs S, Haider A, Warnock GI, Fiechter M, Pargaetzi Y, Rampidis G, Etter D, Wijnen WJ, Portmann A, Osto E: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-7.
  38. Benz DC, Kaufmann PA, von Felten E, Benetos G, Rampidis G, Messerli M, Giannopoulos AA, Fuchs TA, Gräni C, Gebhard C: Prognostic value of quantitative metrics from positron emission tomography in ischemic heart failure. JACC: Cardiovascular Imaging 2020.
  39. Berberat J, Roelcke U, Remonda L, Schwyzer L: Long-term apparent diffusion coefficient value changes in patients undergoing radiosurgical treatment of meningiomas. Acta Neurochirurgica 2020:1-7.
  40. Berger A, Araújo-Filho I, Piffoux M, Nicolás-Boluda A, Grangier A, Boucenna I, Real CC, Marques FLN, de Paula Faria D, do Rego ACM: Local administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing effect in a rat model of colo-cutaneous post-surgical fistula. Nanoscale 2020.
  41. Bertoglio D, Verhaeghe J, Korat Š, Miranda A, Cybulska K, Wyffels L, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M: Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington’s Disease: a Longitudinal PET Study. Molecular neurobiology 2020:1-10.
  42. Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C: Validation and noninvasive kinetic modeling of [11C] UCB-J PET imaging in mice. Journal of Cerebral Blood Flow & Metabolism 2020, 40(6):1351-1362.
  43. Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Dominguez C, Munoz-Sanjuan I, Skinbjerg M, Liu L, Staelens S: Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D 1 R Radioligand [11 C] SCH23390 in Healthy and Diseased Mice. Molecular Imaging and Biology 2020:1-12.
  44. Beyer L, Brendel M, Scheiwein F, Sauerbeck J, Hosakawa C, Alberts I, Shi K, Bartenstein P, Ishii K, Seibyl J: Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer’s Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer’s Disease 2020(Preprint):1-12.
  45. Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Sauerbeck J, Scheifele M, Prix C, Unterrainer M, Catak C, Pogarell O: Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study. NeuroImage: Clinical 2020:102535.
  46. Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J, Marek K, Song M, Palleis C, Respondek G: Early-phase [18 F] PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-12.
  47. Biechele G, Franzmeier N, Blume T, Ewers M, Luque JM, Eckenweber F, Sacher C, Beyer L, Ruch-Rubinstein F, Lindner S: Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. Journal of Neuroinflammation 2020, 17(1):1-10.
  48. Biechele G, Wind K, Blume T, Sacher C, Beyer L, Eckenweber F, Franzmeier N, Ewers M, Zott B, Lindner S: Microglial Activation in the Right Amygdala-Entorhinal-Hippocampal Complex is Associated with Preserved Spatial Learning in AppNL-GF mice. NeuroImage 2020:117707.
  49. Biegon A, Shroyer KR, Franceschi D, Dhawan J, Tahmi M, Pareto D, Bonilla P, Airola K, Cohen J: Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer. Journal of Nuclear Medicine 2020, 61(6):807-813.
  50. Boles Ponto LL, Magnotta VA, Menda Y, Moser DJ, Oleson JJ, Harlynn EL, DeVries SD, Wemmie JA, Schultz SK: Comparison of T1Rho MRI, Glucose Metabolism, and Amyloid Burden Across the Cognitive Spectrum: A Pilot Study. The Journal of Neuropsychiatry and Clinical Neurosciences 2020:appi. neuropsych. 19100221.
  51. Borchert T, Hess A, Lukačević M, Ross TL, Bengel FM, Thackeray JT: Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation. European journal of nuclear medicine and molecular imaging 2020:1-12.
  52. Bremova-Ertl T, Sztatecsny C, Brendel M, Moser M, Möller B, Clevert DA, Beck-Wödl S, Kun-Rodrigues C, Bras J, Rominger A: Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity. Neurology 2020, 94(16):e1702-e1715.
  53. Briest F, Koziolek EJ, Albrecht J, Schmidt F, Bernsen MR, Haeck J, Kühl AA, Sedding D, Hartung T, Exner S: Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms?–A preclinical assessment in vitro and in vivo. Neoplasia 2020, 23(1):80-98.
  54. Brosch J, Gosewisch A, Kaiser L, Seidensticker M, Ricke J, Zellmer J, Bartenstein P, Ziegler S, Ilhan H, Todica A: 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. Physica Medica 2020, 80:317-326.
  55. Brosch J, Uribe C, Gosewisch A, Kaiser L, Todica A, Ilhan H, Gildehaus FJ, Bartenstein P, Rahmim A, Celler A: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T. 2020.
  56. Brumberg J, Schröter N, Blazhenets G, Frings L, Volkmann J, Lapa C, Jost WH, Isaias IU, Meyer PT: Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy. NPJ Parkinson’s disease 2020, 6(1):1-7.
  57. Bullich S, Barret O, Constantinescu C, Sandiego C, Mueller A, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H: Evaluation of Dosimetry, Quantitative Methods, and Test–Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain. Journal of Nuclear Medicine 2020, 61(6):920-927.
  58. Busatto Filho G, Duran FLdS, Squarzoni P, Coutinho AMN, Rosa PGP, Torralbo L, Pachi CGdF, da Costa NA, Porto FHdG, Carvalho CL: Hippocampal subregional volume changes in elders classified using positron emission tomography‐based Alzheimer’s biomarkers of β‐amyloid deposition and neurodegeneration. Journal of Neuroscience Research 2020.
  59. Cai L, Liow J-S, Morse CL, Telu S, Davies R, Frankland MP, Zoghbi S, Cheng K, Hall M, Innis RB: Evaluation of 11C-NR2B-SMe and its Enantiomers as PET Radioligands for Imaging the NR2B Subunit within the NMDA Receptor Complex in Rats. Journal of Nuclear Medicine 2020:jnumed. 119.235143.
  60. Cai M, Yang EJ: Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model. Frontiers in Pharmacology 2020, 11.
  61. Cai X, Zhang K, Xie X, Zhu X, Feng J, Jin Z, Zhang H, Tian M, Chen H: Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials 2020, 231:119678.
  62. Cantero JL, Atienza M, Ramos-Cejudo J, Fossati S, Wisniewski T, Osorio RS: Plasma tau predicts cerebral vulnerability in aging. Aging (Albany NY) 2020, 12(21):21004.
  63. Cao R, Chen X, Xie C, Hu P, Wang K: Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder. Frontiers in Neuroscience 2020, 14:349.
  64. Ceballos‐Francisco D, Carrillo NG, Pardo‐Fernández FJ, Cuesta A, Esteban MÁ: Radiological characterization of gilthead seabream (Sparus aurata) by X‐ray computed tomography. Journal of Fish Biology 2020, 97(5):1440-1447.
  65. Ceballos-Francisco D, García-Carrillo N, Cuesta A, Esteban MÁ: Radiological characterization of gilthead seabream (Sparus aurata) fat by X-ray micro-computed tomography. Scientific Reports 2020, 10(1):1-11.
  66. Ceccon G, Lohmann P, Werner J-M, Tscherpel C, Dunkl V, Stoffels G, Rosen J, Rapp M, Sabel M, Herrlinger U: Early treatment response assessment using 18F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy. Journal of Nuclear Medicine 2020:jnumed. 120.254243.
  67. Chan S-C, Ng S-H, Yeh C-H, Chang K-P: Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonanceimaging functional parameters and 18 F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure. 2020.
  68. Chang C-W, Chiu C-H, Lin M-H, Wu H-M, Yu T-H, Wang P-Y, Kuo Y-Y, Huang Y-Y, Shiue C-Y, Huang W-S: In Vivo Brain Region-specific TSPO Imaging by PET/MRI [18F] FEPPA. 2020.
  69. Chang WH, Chen KC, Tseng H-H, Chiu NT, Lee IH, Chen PS, Yang YK: Bridging the associations between dopamine, brain volumetric variation and IQ in drug-naïve schizophrenia. Schizophrenia Research 2020.
  70. Chastel A, Worm DJ, Alves ID, Vimont D, Petrel M, Fernandez S, Garrigue P, Fernandez P, Hindié E, Beck-Sickinger AG: Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides. EJNMMI research 2020, 10(1):1-12.
  71. Chen K-H, Miao Y-B, Shang C-Y, Huang T-Y, Yu Y-T, Yeh C-N, Song H-L, Chen C-T, Mi F-L, Lin K-J: A bubble bursting-mediated oral drug delivery system that enables concurrent delivery of lipophilic and hydrophilic chemotherapeutics for treating pancreatic tumors in rats. Biomaterials 2020:120157.
  72. Chen Y, Goorden MC, Vastenhouw B, Beekman FJ: Optimized sampling for high resolution multi-pinhole brain SPECT with stationary detectors. Physics in Medicine & Biology 2020, 65(1):015002.
  73. Chen Y-H, Wang T-F, Chu S-C, Lin C-B, Wang L-Y, Lue K-H, Liu S-H, Chan S-C: Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma. PloS one 2020, 15(12):e0244502.
  74. Cherix A, Donati G, Lizarbe B, Lanz B, Poitry-Yamate C, Lei H, Gruetter R: Excitatory/inhibitory neuronal metabolic balance in mouse hippocampus upon infusion of [U-13C6] glucose. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20910535.
  75. Cherix A, Poitry-Yamate C, Lanz B, Zanoletti O, Grosse J, Sandi C, Gruetter R, Cardinaux J-R: Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior. bioRxiv 2020.
  76. Chin W-C, Liu F-Y, Huang Y-S, Hsiao I-T, Wang C-H, Chen Y-C: Different PET findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study. Journal of Clinical Sleep Medicine 2020:jcsm. 9032.
  77. Choi BW, Kim S, Kang S, Won KS, Yi H-A, Kim HW: Relationship between thyroid hormone levels and the pathology of Alzheimer’s disease in euthyroid subjects. Thyroid 2020(ja).
  78. Choi C-H, Stegmayr C, Shymanskaya A, Worthoff WA, da Silva NA, Felder J, Langen K-J, Shah NJ: An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems. 2020.
  79. Chotipanich C, Nivorn M, Kunawudhi A, Promteangtrong C, Boonkawin N, Jantarato A: Evaluation of Imaging Windows for Tau PET Imaging Using 18F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients. Molecular Imaging 2020, 19:1536012120947582.
  80. Chung Y-H, Tsai C-K, Yu C-F, Wang W-L, Yang C-L, Hong J-H, Yen T-C, Chen F-H, Lin G: Radiation-induced Metabolic Shifts in the Hepatic Parenchyma: Findings from 18F-FDG PET Imaging and Tissue NMR Metabolomics in a Mouse Model for Hepatocellular Carcinoma. 2020.
  81. Cisbani G, Koppel A, Knezevic D, Suridjan I, Mizrahi R, Bazinet RP: Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: an exploratory study. Brain, Behavior, and Immunity 2020.
  82. Coda A, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G: In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18 F] DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-13.
  83. Cole K, Pugh T, Cornejo K, Chareonthaitawee P, Johnson G, Kemp B: Clinical evaluation of software for processing 13N-ammonia rest-stress cardiac perfusion PET/CT studies. Journal of Nuclear Medicine 2020, 61(supplement 1):3060-3060.
  84. Contat C, Ancey P-B, Zangger N, Sabatino S, Pascual J, Escrig S, Jensen L, Goepfert C, Lanz B, Lepore M: Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth. Elife 2020, 9:e53618.
  85. Craciun L, de Wind R, Demetter P, Lucidi V, Bohlok A, Michiels S, Bouazza F, Vouche M, Tancredi I, Verset G: Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy. BMC cancer 2020, 20(1):1-10.
  86. Cuenoud B, Hartweg M, Godin J-P, Croteau E, Maltais M, Castellano C-A, Carpentier AC, Cunnane SC: Metabolism of exogenous D-beta-hydroxybutyrate, an energy substrate avidly consumed by the heart and kidney. Frontiers in nutrition 2020, 7:13.
  87. Damuka N, Czoty PW, Davis AT, Nader MA, Nader SH, Craft S, Macauley SL, Galbo LK, Epperly PM, Whitlow CT: PET Imaging of [11C] MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains. Molecules 2020, 25(10):2289.
  88. Darr C, Harke N, Radtke JP, Yirga L, Kesch C, Grootendorst M, Fendler W, Costa PF, Rischpler C, Praus C: Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy–a feasibility study. Journal of Nuclear Medicine 2020:jnumed. 119.240424.
  89. Dawicki W, Allen KJ, Garg R, Geoghegan EM, Berger MS, Ludwig DL, Dadachova E: Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy. Oncotarget 2020, 11(39):3571-3581.
  90. de Arcocha-Torres M, Quincoces G, Martínez-López A, Erhard A, Collantes M, Martínez-Rodríguez I, Ecay M, Banzo I, Irache J, Peñuelas I: Preparación, radiomarcaje con 99mTc y 67Ga y estudios de biodistribución de nanopartículas de albúmina con recubrimientos poliméricos. Revista Española de Medicina Nuclear e Imagen Molecular 2020, 39(4):225-232.
  91. De Leo TC, dos Santos SN, Andrade CDC, Ricci E, Turato WM, Lopes NP, Oliveira RS, Bernardes ES, Dias-Baruffi M: Engineering of galectin-3 for glycan-binding optical imaging. Biochemical and Biophysical Research Communications 2020, 521(3):674-680.
  92. de Lima LI, Faria RS, Franco MS, Roque MC, Arruda Pacheco TJ, Rodrigues MC, Muehlmann LA, Moya SE, Azevedo RB, de Oliveira MC: Combined paclitaxel-doxorubicin liposomal results in positive prognosis with infiltrating lymphocytes in lung metastasis. Nanomedicine 2020, 15(29):2753-2770.
  93. de Redín IL, Expósito F, Agüeros M, Collantes M, Peñuelas I, Allemandi D, Llabot JM, Calvo A, Irache JM: In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer. Drug Delivery and Translational Research 2020:1-11.
  94. de-Arcocha-Torres M: Radiomarcaje de nanopartículas de albúmina con radiometales (Tecnecio-99M, Galoo-67, Zirconio-89) y estudio de su biodistribución mediante imagen molecular. 2020.
  95. Delage J, Faivre-Chauvet A, Fierle J, Gnesin S, Schaefer N, Coukos G, Dunn S, Viertl D, Prior J: 177 Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma. EJNMMI research 2020, 10(1):1-14.
  96. Delva A, Van Weehaeghe D, van Aalst J, Ceccarini J, Koole M, Baete K, Nuyts J, Vandenberghe W, Van Laere K: Quantification and discriminative power of 18 F-FE-PE2I PET in patients with Parkinson’s disease. European journal of nuclear medicine and molecular imaging 2020, 47(8):1913-1926.
  97. Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC: Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body 18 F-FDG PET/CT scans. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-14.
  98. Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C: Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging 2020.
  99. Donat CK, Hansen HH, Hansen HD, Mease RC, Horti AG, Pomper MG, L’Estrade ET, Herth MM, Peters D, Knudsen GM: In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [125I] Iodo-ASEM and [18F] ASEM as Radiotracers of Homo-and Heteromeric α7 Nicotinic Acetylcholine Receptors. Molecules 2020, 25(6):1425.
  100. Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM: Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig. European Neuropsychopharmacology 2020.
  101. Doot RK, Young AJ, Daube-Witherspoon ME, Alexoff D, Labban KJ, Lee H, Wu Z, Zha Z, Choi SR, Ploessl KH: Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga] Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies. Nuclear Medicine and Biology 2020.
  102. Drescher R, Seifert P, Gühne F, Kühnel C, Aschenbach R, Freesmeyer M: Transarterial Radioembolization with Yttrium-90 Glass Microspheres: Distribution of Residual Activity and Flow Dynamics during Administration. Journal of Vascular and Interventional Radiology 2020, 31(9):1467-1474.
  103. Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG: PET imaging of soluble epoxide hydrolase in non-human primate brain with [18 F] FNDP. EJNMMI research 2020, 10(1):1-12.
  104. Dubol M, Trichard C, Leroy C, Granger B, Tzavara ET, Martinot J-L, Artiges E: Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging. Journal of Affective Disorders 2020, 262:273-277.
  105. Durán‐Carabali LE, Kawa Odorcyk F, Greggio S, Teribele Venturin G, Farias Sanches E, Garcia Schu G, Soares Carvalho A, Avila Pedroso T, de Sá Couto‐Pereira N, Costa da Costa J: Pre‐and early postnatal enriched environmental experiences prevent neonatal hypoxia‐ischemia late neurodegeneration via metabolic and neuroplastic mechanisms. Journal of Neurochemistry 2020.
  106. Eckenweber F, Medina-Luque J, Blume T, Sacher C, Biechele G, Wind K, Deussing M, Briel N, Lindner S, Boening G: Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning. Journal of neuroinflammation 2020, 17(1):1-12.
  107. Facchin C, Perez-Liva M, Garofalakis A, Viel T, Certain A, Balvay D, Yoganathan T, Woszczyk J, De Sousa K, Sourdon J: Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment. Theranostics 2020, 10(8):3518.
  108. Falciani C, Zevolini F, Brunetti J, Riolo G, Gracia R, Marradi M, Loinaz I, Ziemann C, Cossío U, Llop J: Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections. International Journal of Nanomedicine 2020, 15:1117.
  109. Fan D-Y, Li H-Y, Chen D-W, Chen Y, Yi X, Yang H, Shi Q-Q, Jiao F-Y, Tang Y, Li Q-M: Chronic hypoperfusion is not associated with cerebral amyloidosis. 2020.
  110. Fang J, Ohba H, Hashimoto F, Tsukada H, Chen F, Liu H: Imaging mitochondrial complex I activation during a vibrotactile stimulation: A PET study using [18F] BCPP-EF in the conscious monkey brain. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X19900034.
  111. Fedorova TD, Knudsen K, Hartmann B, Holst JJ, Viborg Mortensen F, Krogh K, Borghammer P: In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients. Neurogastroenterology & Motility 2020, 32(3):e13759.
  112. Feiner IV, Pulagam KR, Gómez‐Vallejo V, Zamacola K, Baz Z, Caffarel MM, Lawrie CH, Ruiz‐de‐Angulo A, Carril M, Llop J: Therapeutic Pretargeting with Gold Nanoparticles as Drug Candidates for Boron Neutron Capture Therapy. Particle & Particle Systems Characterization 2020, 37(12):2000200.
  113. Feiner IV, Pulagam KR, Uribe KB, Passannante R, Simó C, Zamacola K, Gómez-Vallejo V, Herrero-Álvarez N, Cossío U, Baz Z: Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapy. Journal of Materials Chemistry B 2020.
  114. Feng DD, Chen K, Wen L: Noninvasive Input Function Acquisition and Simultaneous Estimations With Physiological Parameters for PET Quantification: A Brief Review. IEEE Transactions on Radiation and Plasma Medical Sciences 2020, 4(6):676-683.
  115. Fiedorowicz M, Khan M, Strzemecki D, Orzeł J, Wełniak-Kamińska M, Sobiborowicz A, Wieteska M, Rogulski Z, Cheda L, Wargocka-Matuszewska W: Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo. Scientific reports 2020, 10(1):1-19.
  116. Flanigan M, Tollefson S, Himes ML, Jordan R, Roach K, Stoughton C, Lopresti B, Mason NS, Ciccocioppo R, Narendran R: Acute elevations in cortisol increase the in vivo binding of [11C] NOP-1A to nociceptin receptors: A novel imaging paradigm to study the interaction between stress-and antistress-regulating neuropeptides. Biological Psychiatry 2020, 87(6):570-576.
  117. Fleury Curado T, Pho H, Freire C, Amorim MR, Bonaventura J, Kim LJ, Lee R, Cabassa ME, Streeter SR, Branco LG: DREADD Approach to Treatment of Sleep Disordered Breathing. American Journal of Respiratory and Critical Care Medicine 2020(ja).
  118. Franke TN, Irwin C, Bayer TA, Brenner W, Beindorff N, Bouter C, Bouter Y: In vivo imaging with 18F-FDG-and 18F-Florbetaben-PET/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer’s disease. Frontiers in Medicine 2020, 7:529.
  119. Freitas RD, Muradás TC, Dagnino APA, Rost FL, Costa KM, Venturin GT, Greggio S, da Costa JC, Campos MM: Targeting FFA1 and FFA4 receptors in cancer-induced cachexia. American Journal of Physiology-Endocrinology and Metabolism 2020, 319(5):E877-E892.
  120. Fuenfgeld B, Mächler P, Fischer DR, Esposito G, Rushing EJ, Kaufmann PA, Stolzmann P, Huellner MW: Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination. Plos one 2020, 15(4):e0230618.
  121. Fung LK, Flores RE, Gu M, Sun KL, James D, Schuck RK, Jo B, Park JH, Lee BC, Jung JH: Thalamic and prefrontal GABA concentrations but not GABA A receptor densities are altered in high-functioning adults with autism spectrum disorder. Molecular Psychiatry 2020:1-13.
  122. Gao Y, Wu S, Pan J, Zhang K, Li X, Xu Y, Jin C, He X, Shi J, Ma L: CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-13.
  123. García-Varela L, Arif WM, Vállez García D, Kakiuchi T, Ohba H, Harada N, Tago T, Elsinga PH, Tsukada H, Colabufo NA: Pharmacokinetic Modeling of [18F] MC225 for Quantification of the P-Glycoprotein Function at the Blood–Brain Barrier in Non-Human Primates with PET. Molecular pharmaceutics 2020, 17(9):3477-3486.
  124. García-Varela L, García DV, Kakiuchi T, Ohba H, Nishiyama S, Tago T, Elsinga PH, Tsukada H, Colabufo NA, Dierckx RA: Pharmacokinetic Modeling of (R)-[11C] verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates. Molecular Pharmaceutics 2020.
  125. García-Varela L, Vállez García D, Rodríguez-Pérez M, van Waarde A, Sijbesma JrW, Schildt A, Kwizera C, Aguiar P, Sobrino T, Dierckx RA: Test–Retest Repeatability of [18F] MC225-PET in Rodents: A Tracer for Imaging of P-gp Function. ACS chemical neuroscience 2020, 11(4):648-658.
  126. Garg PK, Putegnat B, Truong L, Reynolds C, Sanchez I, Nedrelow JK, Uffman J, Lokitz SJ, Nazih R, Garg S: Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism. Plos one 2020, 15(10):e0241243.
  127. Garrido A, Iranzo A, Stefani A, Serradell M, Muñoz‐Lopetegi A, Marrero P, Högl B, Gaig C, Santamaria J, Tolosa E: Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects. Movement Disorders 2020.
  128. Garrow AA, Andrews JP, Gonzalez ZN, Corral CA, Portal C, Morgan TE, Walton T, Wilson I, Newby DE, Lucatelli C: Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers. Scientific reports 2020, 10(1):1-11.
  129. Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP: The interaction between neuroinflammation and β-amyloid in cognitive decline in Parkinson’s Disease. Molecular neurobiology 2020, 57(1):492-501.
  130. Giacobbo BL, Doorduin J, Moraga-Amaro R, Nazario LR, Schildt A, Bromberg E, Dierckx RA, de Vries EF: Chronic harmine treatment has a delayed effect on mobility in control and socially defeated rats. Psychopharmacology 2020:1-12.
  131. Giovannella M, Andresen B, Andersen JB, El-Mahdaoui S, Contini D, Spinelli L, Torricelli A, Greisen G, Durduran T, Weigel UM: Validation of diffuse correlation spectroscopy against 15O-water PET for regional cerebral blood flow measurement in neonatal piglets. Journal of Cerebral Blood Flow & Metabolism 2020, 40(10):2055-2065.
  132. Girard A, Saint-Jalmes H, Chaboub N, Le Reste P-J, Metais A, Devillers A, Le Jeune F, Palard-Novello X: Optimization of time frame binning for FDOPA uptake quantification in glioma. Plos one 2020, 15(4):e0232141.
  133. Girardet R, Boughdad S, Digklia A, Beigelman C, Meyer M, Schaefer N, Vermersch M, Hocquelet A, Tsoumakidou G, Denys A: Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium. Cardiovascular and interventional radiology 2020, 43(11):1712-1715.
  134. Giridharan VV, Collodel A, Generoso JS, Scaini G, Wassather R, Selvaraj S, Hasbun R, Dal-Pizzol F, Petronilho F, Barichello T: Neuroinflammation trajectories precede cognitive impairment after experimental meningitis—evidence from an in vivo PET study. Journal of Neuroinflammation 2020, 17(1):1-20.
  135. Glorie D, Verhaeghe J, Miranda A, De Lombaerde S, Stroobants S, Staelens S: Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [11 C] UCB-J PET study in a model of obsessive–compulsive disorder-like behaviour. EJNMMI research 2020, 10(1):1-13.
  136. Glorie D, Verhaeghe J, Miranda A, Kertesz I, Wyffels L, Stroobants S, Staelens S: Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: A longitudinal [11C] ABP688 PET study. Neuropharmacology 2020:108160.
  137. Gnesin S, Kieffer C, Zeimpekis K, Papazyan J-P, Guignard R, Prior JO, Verdun FR, Lima TV: Phantom-based image quality assessment of clinical 18 F-FDG protocols in digital PET/CT and comparison to conventional PMT-based PET/CT. EJNMMI physics 2020, 7(1):1-16.
  138. Gnesin S, Müller J, Burger IA, Meisel A, Siano M, Früh M, Choschzick M, Müller C, Schibli R, Ametamey SM: Radiation dosimetry of 18 F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI research 2020, 10:1-12.
  139. Golan S, Aviv T, Groshar D, Yakimov M, Zohar Y, Nadu A, Baniel J, Domachevsky L, Bernstine H: Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study. Journal of Nuclear Medicine 2020:jnumed. 120.251272.
  140. Gómez-Gónzalez E, Núñez NO, Caro C, García-Martín ML, Fernández-Afonso Y, de la Fuente JsM, Balcerzyk M, Ocaña M: Dysprosium and Holmium Vanadate Nanoprobes as High-Performance Contrast Agents for High-Field Magnetic Resonance and Computed Tomography Imaging. Inorganic Chemistry 2020.
  141. Gómez-Lado N, López-Arias E, Iglesias-Rey R, Díaz-Platas L, Medín-Aguerre S, Fernández-Ferreiro A, Posado-Fernández A, García-Varela L, Rodríguez-Pérez M, Campos F: [18F]-FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage. Molecular Pharmaceutics 2020.
  142. Gorbenko I, Mikołajczyk K, Jasionowska M, Narloch J, Kałużyński K: Automatic segmentation of facial soft tissue in MRI data based on non-rigid normalization in application to soft tissue thickness measurement. Biomedical Signal Processing and Control 2020, 56:101698.
  143. Goutal S, Guillermier M, Becker G, Gaudin M, Bramoullé Y, Luxen A, Lemaire C, Plenevaux A, Salmon E, Hantraye P: The Pharmacokinetics of [18F] UCB-H Revisited in The Healthy Non-Human Primate Brain. 2020.
  144. Goutal S, Tournier N, Guillermier M, Van Camp N, Barret O, Gaudin M, Bottlaender M, Hantraye P, Lavisse S: Comparative test-retest variability of outcome parameters derived from brain [18F] FDG PET studies in non-human primates. Plos one 2020, 15(10):e0240228.
  145. Grachev ID, Meyer PM, Becker GA, Bronzel M, Marsteller D, Pastino G, Voges O, Rabinovich L, Knebel H, Zientek F: Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18 F] fluspidine and [18 F] fallypride PET study. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-13.
  146. Grecco GG, Mork B, Huang JY, Metzger CE, Haggerty DL, Reeves KC, Gao Y, Hoffman H, Katner SN, Masters AR: Prenatal Methadone Exposure Disrupts Behavioral Development and Alters Motor Neuron Intrinsic Properties and Local Circuitry. bioRxiv 2020.
  147. Grimmer T, Shi K, Diehl-Schmid J, Natale B, Drzezga A, Förster S, Förstl H, Schwaiger M, Yakushev I, Wester H-J: 18 F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases. Molecular psychiatry 2020, 25(10):2608-2619.
  148. Grosch M, Lindner M, Bartenstein P, Brandt T, Dieterich M, Ziegler S, Zwergal A: Dynamic whole-brain metabolic connectivity during vestibular compensation in the rat. NeuroImage 2020, 226:117588.
  149. Gruber L, Jimenez-Franco LD, Decristoforo C, Uprimny C, Glatting G, Hohenberger P, Schoenberg SO, Reindl W, Orlandi F, Mariani M: MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients. Journal of Nuclear Medicine 2020:jnumed. 119.238808.
  150. Guarra F, Terenzi A, Pirker C, Passannante R, Baier D, Zangrando E, Gómez V, Biver T, Gabbiani C, Berger W: 124I-radiolabeling of a Au (III)-NHC complex for in vivo biodistribution studies. 2020.
  151. Guibbal F, Hopkins SL, Pacelli A, Isenegger PG, Mosley M, Torres JB, Dias GM, Mahaut D, Hueting R, Gouverneur V: [18 F] AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET Imaging. Molecular Imaging and Biology 2020, 22(5):1226-1234.
  152. Haider A, Gobbi L, Kretz J, Ullmer C, Brink A, Honer M, Woltering TJ, Muri D, Iding H, Bürkler M: Identification and Preclinical Development of a 2, 5, 6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. Journal of Medicinal Chemistry 2020, 63(18):10287-10306.
  153. Harris DA, Mina A, Cabarkapa D, Heshmati K, Subramaniam R, Banks AS, Tavakkoli A, Sheu EG: Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss. American Journal of Physiology-Endocrinology and Metabolism 2020, 318(5):E678-E688.
  154. Hartley SL, Handen BL, Devenny D, Tudorascu D, Piro‐Gambetti B, Zammit MD, Laymon CM, Klunk WE, Zaman S, Cohen A: Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer’s disease in Down syndrome. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12096.
  155. Hashimoto F, Ohba H, Ote K, Kakimoto A, Tsukada H, Ouchi Y: 4D deep image prior: dynamic PET image denoising using an unsupervised four-dimensional branch convolutional neural network. Physics in Medicine & Biology 2020.
  156. Hauser EB, Venturin GT, Greggio S, Borelli WV, DaCosta J: Carotid arterial input function as an inverse problem in kinetic modeling of [18F] 2-fluoro-2 deoxy-D-glucose (FDG). Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2020, 8(3):273-276.
  157. Hayashi H, Kobayashi R, Kawakatsu S, Morioka D, Otani K: Utility of Easy Z-Score Imaging System-Assisted SPECT in Detecting Onset Age-Dependent Decreases in Cerebral Blood Flow in the Posterior Cingulate Cortex, Precuneus, and Parietal Lobe in Alzheimer’s Disease with Amyloid Accumulation. Dementia and Geriatric Cognitive Disorders Extra 2020, 10(2):63-68.
  158. He RY, Lai XM, Sun CS, Kung TS, Hong JY, Jheng YS, Liao WN, Chen JK, Liao YF, Tu PH: Nanoscopic insights of amphiphilic peptide against the oligomer assembly process to treat Huntington’s disease. Advanced Science 2020, 7(2):1901165.
  159. He Y, Whitehead DM, Briard E, Numao S, Mu L, Schibli R, Ametamey SM, Auberson YP: Evaluation of 5H‐Thiazolo [3, 2‐α] pyrimidin‐5‐ones as Potential GluN2A PET Tracers. ChemMedChem 2020, 15(24):2448-2461.
  160. Hepp T, Othman A, Liebgott A, Kim JH, Pfannenberg C, Gatidis S: Effects of simulated dose variation on contrast-enhanced CT-based radiomic analysis for Non-Small Cell Lung Cancer. European Journal of Radiology 2020, 124:108804.
  161. Hernández Lozano I, Langer O: Use of imaging to assess the activity of hepatic transporters. Expert Opinion on Drug Metabolism & Toxicology 2020, 16(2):149-164.
  162. Hirai N, Watabe T, Nagamori S, Wiriyasermkul P, Tanaka Y, Romanov V, Naka S, Kanai Y, Liu Y, Tani N: Evaluation of D-isomer of 18F-FBPA for oncology PET focusing on the differentiation of glioma and inflammation. Asia Oceania Journal of Nuclear Medicine and Biology 2020, 8(2):102.
  163. Hiroyama S, Rokugawa T, Ito M, Iimori H, Morita I, Maeda H, Fujisawa K, Matsunaga K, Shimosegawa E, Abe K: Quantitative evaluation of hepatic integrin α v β 3 expression by positron emission tomography imaging using 18 F-FPP-RGD 2 in rats with non-alcoholic steatohepatitis. EJNMMI research 2020, 10(1):1-12.
  164. Holodňáková N: In vitro saturačné štúdie gáliom-67 a zirkóniom-89 značenej monoklonálnej protilátky ramucirumab na SKOV-3 bunkovej línii. 2020.
  165. Hori Y, Nagai Y, Mimura K, Suhara T, Higuchi M, Bouret S, Minamimoto T: Differential Contribution of Dopaminergic Transmission at D1-and D2-like Receptors to Cost/Benefit Evaluation for Motivation in Monkeys. bioRxiv 2020.
  166. Houben RH, Kotsougiani D, Friedrich PF, Shin AY, Bishop AT: Outcomes of vascularized bone allotransplantation with surgically induced autogenous angiogenesis in a large animal model: bone healing, remodeling, and material properties. Journal of reconstructive microsurgery 2020, 36(02):082-092.
  167. Houben RH, Thaler R, Kotsougiani D, Friedrich PF, Shin AY, van Wijnen AJ, Bishop AT: Neo‐Angiogenesis, Transplant Viability, and Molecular Analyses of Vascularized Bone Allotransplantation Surgery in a Large Animal Model. Journal of Orthopaedic Research® 2020, 38(2):288-296.
  168. Hsu J-L, Chen S-H, Hsiao T, Lu C-S, Yen T-C, Okamura N, Lin K-J, Weng Y-H: 18 F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty. Scientific reports 2020, 10(1):1-10.
  169. Hsu M-N, Huang K-L, Yu F-J, Lai P-L, Truong AV, Lin M-W, Nguyen NTK, Shen C-C, Hwang S-M, Chang Y-H: Coactivation of endogenous Wnt10b and Foxc2 by CRISPR activation enhances BMSC osteogenesis and promotes calvarial bone regeneration. Molecular Therapy 2020, 28(2):441-451.
  170. Hsu M-N, Yu F-J, Chang Y-H, Huang K-L, Pham NN, Truong VA, Lin M-W, Nguyen NTK, Hwang S-M, Hu Y-C: CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing. Biomaterials 2020:120094.
  171. Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG: 18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography. European Journal of Medicinal Chemistry 2020:113047.
  172. Hu W, Pan D, Wang Y, Bao W, Zuo C, Guan Y, Hua F, Yang M, Zhao J: PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [18F] DPA714. Frontiers in Neuroscience 2020, 14.
  173. Huang C, Ding F, Hu Z, Wang M, Peng W, Li W, Wang C, Tang D: 18F-VUIIS1009B Features a Superior Imaging Performance to 18F-DPA-714 in TSPO Density Characterization for Neuroinflammatory PET Imaging. 2020.
  174. Huang CW, Chang YH, Lee HH, Wu JY, Huang JX, Chung YH, Hsu ST, Chow LP, Wei KC, Huang FT: Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma. The FASEB Journal 2020.
  175. Huang K-L, Hsiao T, Ho M-Y, Hsu J-L, Chang Y-J, Chang T-Y, Liu C-H, Chang C-H, Wu Y-M, Wu K-Y: Investigation of reactive astrogliosis effect on post-stroke cognitive impairment. Journal of neuroinflammation 2020, 17(1):1-14.
  176. Huang S, Zhang L, Xu M, Li C, Fu H, Huang J, Jin X, Liang S, Wang H: Co‐Delivery of 131I and Prima‐1 by Self‐Assembled CD44‐Targeted Nanoparticles for Anaplastic Thyroid Carcinoma Theranostics. Advanced Healthcare Materials 2020:2001029.
  177. Huang S-Y, Hsu J-L, Lin K-J, Hsiao I-T: A novel Individual metabolic brain network for 18F-FDG PET imaging. Frontiers in Neuroscience 2020, 14:344.
  178. Huber FA, Schumann P, Von Spiczak J, Wurnig MC, Klarhöfer M, Finkenstaedt T, Bedogni A, Guggenberger R: Medication-Related Osteonecrosis of the Jaw—Comparison of Bone Imaging Using Ultrashort Echo-Time Magnetic Resonance Imaging and Cone-Beam Computed Tomography. Investigative Radiology 2020, 55(3):160-167.
  179. Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R: Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement disorders 2020, 35(4):595-605.
  180. Hunt BC, Stanford D, Xu X, Li J, Gaggar A, Rowe SM, Raju SV, Swords WE: Haemophilus influenzae persists in biofilm communities in a smoke-exposed ferret model of COPD. ERJ Open Research 2020, 6(3).
  181. Iikuni S, Watanabe H, Shimizu Y, Nakamoto Y, Ono M: PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide. Plos one 2020, 15(12):e0243327.
  182. Inubushi T, Ito M, Mori Y, Futatsubashi M, Sato K, Ito S, Yokokura M, Shinke T, Kameno Y, Kakimoto A: Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release. NeuroImage 2020, 224:117434.
  183. Ito Y, Fujita N, Hara K, Tada T, Abe S, Katsuno M, Naganawa S, Kato K: New Semi-Quantification Approach for Dopamine Transporter Scan: Quantification of Accumulation by Examining the Approximate Image. 2020.
  184. Ito Y, Tada T, Murayama R, Ikeda H, Ochi Y, Tamura M, Tsutsumi Y, Kato K: Studies on Calculation of the Specific Binding Ratio with the Minimum Partial Volume Effect for the Caudate and Putamen by Generating the Analogy Image to the Image Obtained by SPECT Imaging. Journal of Nuclear Medicine 2020, 61(supplement 1):3130-3130.
  185. Jeuken RM, Roth AK, Peters MJ, Welting TJ, van Rhijn LW, Koenen J, Peters RJ, Thies JC, Emans PJ: In vitro and in vivo study on the osseointegration of BCP‐coated versus uncoated nondegradable thermoplastic polyurethane focal knee resurfacing implants. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2020, 108(8):3370-3382.
  186. Jiang D, Kong Y, Ren S, Cai H, Zhang Z, Huang Z, Peng F, Hua F, Guan Y, Xie F: Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT. Nuclear Medicine and Biology 2020, 82:89-95.
  187. Jiang D, Qiu X, Ren S, Hua F, Kong Y, Guan Y, Xie F: Maturation of topological organization of brain networks in male adolescent rats: A longitudinal FDG-PET study. Neuroscience Letters 2020:134864.
  188. Jiang D, Shao D, Huang Q, Ren S, Li J, Xiao J, Guan Y, Lai B, Zhao J, Hua F: Brain Glucose Metabolism and Dopamine Transporters Change in Addiction and Environmental Cue-Induced Memory. 2020.
  189. Jiménez-González S, Marín-Royo G, Jurado-López R, Bartolomé MV, Romero-Miranda A, Luaces M, Islas F, Nieto ML, Martínez-Martínez E, Cachofeiro V: The Crosstalk between Cardiac Lipotoxicity and Mitochondrial Oxidative Stress in the Cardiac Alterations in Diet-Induced Obesity in Rats. Cells 2020, 9(2):451.
  190. Johnson TB, Brudvig JJ, Lehtimäki KK, Cain JT, White KA, Bragge T, Rytkönen J, Huhtala T, Timm D, Vihma M: A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease. Progress in Neurobiology 2020:101789.
  191. Joo Y-H, Kim Y-K, Choi I-G, Kim H-J, Son Y-D, Kim H-K, Cumming P, Kim J-H: In vivo glucose metabolism and glutamate levels in mGluR5 knockout mice: a multimodal neuroimaging study using [18 F] FDG microPET and MRS. EJNMMI research 2020, 10(1):1-10.
  192. Kang Y, Rúa SMH, Kaunzner UW, Perumal J, Nealon N, Qu W, Kothari PJ, Vartanian T, Kuceyeski A, Gauthier SA: A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis. multiple sclerosis 2020, 4:12-14.
  193. Karlsson HK, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Mesolimbic opioid-dopamine interaction is disrupted in obesity but recovered by weight loss following bariatric surgery. bioRxiv 2020.
  194. Katayama D, Yanagawa M, Matsunaga K, Watabe H, Watabe T, Kato H, Kijima T, Takeda Y, Kumanogoh A, Shimosegawa E: 15O-Water Dynamic Positron Emission Tomography in Patients with Non-Small Cell Lung Cancer: Early Decrease in Blood Flow After Anti-Angiogenic Treatment is Correlated with a Shorter Time to Tumour Progression. 2020.
  195. Kato H, Okuno T, Isohashi K, Koda T, Shimizu M, Mochizuki H, Nakatsuji Y, Hatazawa J: Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20911469.
  196. Kautzky A, Vanicek T, Philippe C, Kranz G, Wadsak W, Mitterhauser M, Hartmann A, Hahn A, Hacker M, Rujescu D: Machine learning classification of ADHD and HC by multimodal serotonergic data. Translational psychiatry 2020, 10(1):1-9.
  197. Kessler M, Mamach M, Beutelmann R, Lukacevic M, Eilert S, Bascuñana P, Fasel A, Bengel F, Bankstahl J, Ross T: GABA A receptors in the mongolian gerbil: A PET study using [18 F] flumazenil to determine receptor binding in young and old animals. Molecular imaging and biology 2020, 22(2):335-347.
  198. Key MC: The effects of HIV-1 transactivator of transcription (Tat) on synaptic density in the Tat mouse model of HIV-1 associated neurocognitive disorder (HAND)(Under the direction of Sylvia Fitting). 2020.
  199. Khalmuratova R, Lee M, Park J-W, Shin H-W: Evaluation of Neo-Osteogenesis in Eosinophilic Chronic Rhinosinusitis Using a Nasal Polyp Murine Model. Allergy, Asthma & Immunology Research 2020, 12(2):306-321.
  200. Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park M-A, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H: Quantitative [18 F] florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. European journal of nuclear medicine and molecular imaging 2020, 47(8):1998-2009.
  201. Kim D, Ko HY, Lee S, Lee Y-h, Ryu S, Kim SY, Chung J-i, Lee M, Moon JH, Chang JH: Glucose Loading Enhances the Value of 18F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas. Cancers 2020, 12(7):1977.
  202. Kim K, Son SM, Goh TS, Pak K, Kim I-J, Lee JS, Kim S-J: Prediction of Response to Tumor Necrosis Value–α Blocker Is Suggested by 18F-NaF SUVmax But Not by Quantitative Pharmacokinetic Analysis in Patients With Ankylosing Spondylitis. American Journal of Roentgenology 2020:1-7.
  203. Kim M-J, Lee J-H, Anaya FJ, Hong J, Miller W, Telu S, Singh P, Cortes MY, Henry K, Tye GL: First-in-human evaluation of [11C] PS13, a novel PET radioligand, to quantify cyclooxygenase-1 in the brain. European journal of nuclear medicine and molecular imaging 2020.
  204. Kim SE, Joo YH, Son YD, Kim HK, Lee SY, Lee MW, Ido T, Kim JH: Association between human gray matter metabotropic glutamate receptor‑5 availability in vivo and white matter properties: a [11C] ABP688 PET and diffusion tensor imaging study. Brain Structure & Function 2020.
  205. Kjærgaard K, Frisch K, Sørensen M, Munk OL, Hofmann AF, Horsager J, Schacht AC, Erickson M, Shapiro D, Keiding S: Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. Journal of Hepatology 2020, 74(1):58-65.
  206. Kjærgaard K, Sandahl TD, Frisch K, Vase KH, Keiding S, Vilstrup H, Ott P, Gormsen LC, Munk OL: Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu] copper PET/CT. 2020.
  207. Kjærgaard K, Weber B, Alstrup AKO, Petersen JBB, Hansen R, Hamilton-Dutoit SJ, Mortensen FV, Sørensen M: Hepatic regeneration following radiation-induced liver injury is associated with increased hepatobiliary secretion measured by PET in Göttingen minipigs. Scientific Reports 2020, 10(1):1-10.
  208. Klein J, Yan X, Johnson A, Tomljanovic Z, Zou J, Polly K, Honig LS, Brickman A, Stern Y, Devanand D: Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer’s disease. medRxiv 2020.
  209. Klinge MW, Borghammer P, Lund S, Fedorova T, Knudsen K, Haase AM, Christiansen JJ, Krogh K: Enteric cholinergic neuropathy in patients with diabetes: Non‐invasive assessment with positron emission tomography. Neurogastroenterology & Motility 2020, 32(1):e13731.
  210. Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart S: Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling. Journal of Nuclear Medicine 2020, 61(7):1006-1013.
  211. Ko K-Y, Wang S-Y, Yen R-F, Shiau Y-C, Hsu J-C, Tsai H-Y, Lee C-L, Chiu K-M, Wu Y-W: Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy. Journal of Nuclear Cardiology 2020, 27(1):269-279.
  212. Kode J, Kovvuri J, Nagaraju B, Jadhav S, Barkume M, Sen S, Kasinathan NK, Chaudhari P, Mohanty BS, Gour J: Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors. Bioorganic Chemistry 2020, 105:104447.
  213. Koh XY, Koh XH, Spiegelberg D, Jha P, Nestor M, Hwang L-a, Tan BX, Lane D: Picomolar Binding Selective Human Ron Inhibitory Antibodies Directed to Surface Displayed Conformational Epitopes for Imaging and Therapy. 2020.
  214. Komorowski A, Weidenauer A, Murgaš M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S: Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain. NeuroImage 2020, 223:117270.
  215. Koole M, Van Weehaeghe D, Serdons K, Herbots M, Cawthorne C, Celen S, Schroeder FA, Hooker JM, Bormans G, de Hoon J: Clinical validation of the novel HDAC6 radiotracer [18 F] EKZ-001 in the human brain. European journal of nuclear medicine and molecular imaging 2020:1-16.
  216. Kosinski M, Figiel-Dabrowska A, Lech W, Wieprzowski L, Strzalkowski R, Strzemecki D, Cheda L, Lenart J, Domanska-Janik K, Sarnowska A: Bone Defect Repair Using a Bone Substitute Supported by Mesenchymal Stem Cells Derived from the Umbilical Cord. Stem Cells International 2020, 2020.
  217. Kostiv U, Kučka J, Lobaz V, Kotov N, Janoušková O, Šlouf M, Krajnik B, Podhorodecki A, Francová P, Šefc L: Highly colloidally stable trimodal 125 I-radiolabeled PEG-neridronate-coated upconversion/magnetic bioimaging nanoprobes. Scientific reports 2020, 10(1):1-14.
  218. Kramer V, Brooks AF, Haeger A, Kuljis RO, Rafique W, Koeppe RA, Raffel DM, Frey KA, Amaral H, Scott PJ: Evaluation of [18F]-N-Methyl lansoprazole as a Tau PET Imaging Agent in First-in-Human Studies. ACS Chemical Neuroscience 2020, 11(3):427-435.
  219. Kramer V, Dyssegaard A, Flores J, Soza-Ried C, Rösch F, Knudsen GM, Amaral H, Herth MM: Characterization of the serotonin 2A receptor selective PET tracer (R)-[18 F] MH. MZ in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(2):355-365.
  220. Kramer V, Juri C, Riss PJ, Pruzzo R, Soza-Ried C, Flores J, Hurtado A, Rösch F, Chana-Cuevas P, Amaral H: Pharmacokinetic evaluation of [18 F] PR04. MZ for PET/CT imaging and quantification of dopamine transporters in the human brain. European journal of nuclear medicine and molecular imaging 2020, 47(8):1927-1937.
  221. Kristoffer K, Weber B, Olsen AAK, Baltzer PJB, Hansen R, Hamilton-Dutoit SJ, Mortensen FV, Sørensen M: Hepatic regeneration following radiation-induced liver injury is associated with increased hepatobiliary secretion measured by PET in Göttingen minipigs. Scientific Reports (Nature Publisher Group) 2020, 10(1).
  222. Kubota M, Fujino J, Tei S, Takahata K, Matsuoka K, Tagai K, Sano Y, Yamamoto Y, Shimada H, Takado Y: Binding of Dopamine D1 Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study. Cerebral Cortex 2020, 30(12):6458-6468.
  223. Kuhla A, Meuth L, Stenzel J, Lindner T, Lappe C, Kurth J, Krause BJ, Teipel S, Glass Ä, Kundt G: Longitudinal [18 F] FDG-PET/CT analysis of the glucose metabolism in ApoE-deficient mice. EJNMMI research 2020, 10(1):1-11.
  224. Kühnel C, Seifert P, Mulik C, Winkens T, Freesmeyer M: 3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration. Nuklearmedizin 2020, 59(01):12-19.
  225. Kumamoto K, Katsube S, Tsubaki Y, Sato H, Tsutsui Y, Himuro K, Baba S, Sasaki M: Comparison of continuous bed motion and step-and-shoot method in SiPM PET/CT. Journal of Nuclear Medicine 2020, 61(supplement 1):3017-3017.
  226. Kushchayeva YS, Startzell M, Cochran E, Auh S, Sekizkardes H, Soldin SJ, Kushchayev SV, Dieckmann W, Skarulis M, Abdul Sater Z: Thyroid hormone effects on glucose disposal in patients with insulin receptor mutations. The Journal of Clinical Endocrinology & Metabolism 2020, 105(3):e158-e171.
  227. Kwon IG, Kang CW, Park J-P, Oh JH, Wang EK, Kim TY, Sung JS, Park N, Lee YJ, Sung H-J: Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment. Gut 2020.
  228. LAN Y, Bai P, Wang H, Wang C: Design and preclinical evaluation of [18F] CNY-05, a next generation of sigma-1 receptor (ó1R) radiotracer for brain imaging of positron emission tomography (PET). Journal of Nuclear Medicine 2020, 61(supplement 1):202-202.
  229. LAN Y, Bai P, Wang H, Wang C: Design and preclinical evaluation of [11C] CNY-06, the firest generation of RIPK1/necroptosis radiotracer for brain imaging of positron emission tomography (PET). Journal of Nuclear Medicine 2020, 61(supplement 1):1035-1035.
  230. Landau AM, Noer O, Alstrup AKO, Audrain H, Wegener G, Gjedde A, Doudet DJ, Winterdahl M: Type of Anaesthetic Influences [11 C] MDL100, 907 Binding to 5HT 2A Receptors in Porcine Brain. Molecular Imaging and Biology 2020:1-8.
  231. Langaa SS, Lauridsen TG, Mose FH, Fynbo CA, Theil J, Bech JN: Estimation of renal perfusion based on measurement of Rubidium-82 clearance by PET/CT scanning in healthy subjects. 2020.
  232. Larsen B, Olafsson V, Calabro F, Laymon C, Tervo-Clemmens B, Campbell E, Minhas D, Montez D, Price J, Luna B: Maturation of the human striatal dopamine system revealed by PET and quantitative MRI. Nature communications 2020, 11(1):1-10.
  233. Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M, Keinänen J, Mäntylä T, Paju J, Ilonen T: Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Translational psychiatry 2020, 10(1):1-14.
  234. Ledermann K, Hasler G, Jenewein J, Sprott H, Schnyder U, Martin‐Soelch C: 5ʹUTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls—Preliminary evidence. Synapse 2020, 74(5):e22147.
  235. Lee J-H, Go Y, Kim D-Y, Lee SH, Kim O-H, Jeon YH, Kwon TK, Bae J-H, Song D-K, Lee I-K: Isocitrate dehydrogenase 2 protects mice from high-fat diet-induced metabolic stress by limiting oxidative damage to the mitochondria from brown adipose tissue. Experimental & molecular medicine 2020, 52(2):238-252.
  236. L’Estrade ET, Shalgunov V, Edgar FG, Strebl‐Bantillo MG, Xiong M, Crestey F, Neelamegam R, Dyssegaard A, Lehel S, Erlandsson M: Radiosynthesis and preclinical evaluation of [11C] Cimbi‐701–Towards the imaging of cerebral 5‐HT7 receptors. Journal of Labelled Compounds and Radiopharmaceuticals 2020, 63(2):46-55.
  237. Lew R, Constantinescu CC, Holden D, Carson RE, Carroll V, Galluppi G, Koblan KS, Hopkins SC: The rate of dasotraline brain entry is slow following intravenous administration. Psychopharmacology 2020, 237(11):3435-3446.
  238. Lhamyani S, Gentile A-M, Giraldez-Perez RM, Feijoo-Cuaresma M, Romero-Zerbo SY, Clemente-Postigo M, Zayed H, Oliva-Olivera W, Bermudez-Silva FJ, Salas J: miR-21 blocks obesity in mice: a potential therapy for humans. medRxiv 2020.
  239. Li CH, Fan SP, Chen TF, Chiu MJ, Yen RF, Lin CH: Frontal variant of Alzheimer’s disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review. Brain and Behavior 2020, 10(3):e01548.
  240. Li F, Taylor E, Yeung I, Jaffray D, Metser U, Dhani N, Hedley DW, Lee T-Y: Pharmacokinetic Analysis of Dynamic [18F] FAZA PET Imaging in Pancreatic Cancer Patient. 2020.
  241. Li J, Joseph T, Ghorbani Asl M, Kolekar S, Krasheninnikov A, Batzill M: Publications Repository-Helmholtz-Zentrum Dresden-Rossendorf. Physical Review B 2020, 101:054438.
  242. Li LLL, Kuo H-T, Wang X, Merkens H, Colpo N, Radchenko V, Schaffer P, Lin K-S, Benard F, Orvig C: tBu4octapa-alkyl-NHS for Metalloradiopeptide Preparation. Dalton Transactions 2020.
  243. Li M-H, Chang H-C, Feng C-F, Yu H-W, Shiue C-Y: Synthesis and Evaluation of 18F-INER-1577-3 as a Central Nervous System (CNS) Histone Deacetylase Imaging Agent. Current Medical Imaging 2020, 16(8):978-990.
  244. Li S, Daamen M, Scheef L, Gaertner FC, Buchert R, Buchmann M, Buerger K, Catak C, Dobisch L, Drzezga A et al: Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status. J Alzheimers Dis 2020.
  245. Li W, Wang Y, Rubins D, Bennacef I, Holahan M, Haley H, Purcell M, Gantert L, Hseih S, Judo M: PET/CT Imaging of 89 Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys. Molecular Imaging and Biology 2020:1-10.
  246. Liapis V, Tieu W, Rudd SE, Donnelly PS, Wittwer NL, Brown MP, Staudacher AH: Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®. EJNMMI radiopharmacy and chemistry 2020, 5(1):1-15.
  247. Liapis V, Tieu W, Wittwer N, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH: Positron Emission Tomographic imaging of tumor cell death using Zirconium-89-labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models. 2020.
  248. Lien VT, Celen S, Nuruddin S, Attili B, Doumont G, Van Simaeys G, Bormans G, Klaveness J, Olberg DE: Preclinical evaluation of [18F] cabozantinib as a PET imaging agent in a prostate cancer mouse model. Nuclear Medicine and Biology 2020.
  249. Lin H-C, Chan S-C, Cheng N-M, Liao C-T, Hsu C-L, Wang H-M, Lin C-Y, Chang JT-C, Ng S-H, Yang L-Y: Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma. Oral Oncology 2020, 104:104628.
  250. Lin S-H, Chi MH, Lee IH, Chen KC, Tai YC, Yao WJ, Chiu NT, Yang D-Y, Lin C-Y, Chen PS: A pilot study on the association between the blood oxygen level-dependent signal in the reward system and dopamine transporter availability in adults with attention deficit hyperactivity disorder. CNS spectrums 2020:1-8.
  251. Lindemann M, Moldovan R-P, Hinz S, Deuther-Conrad W, Gündel D, Dukic-Stefanovic S, Toussaint M, Teodoro R, Juhl C, Steinbach J: Development of a Radiofluorinated Adenosine A2B Receptor Antagonist as Potential Ligand for PET Imaging. International journal of molecular sciences 2020, 21(9):3197.
  252. Lindner T, Stenzel J, Koslowski N, Hohn A, Glass Ä, Schwarzenböck SM, Krause BJ, Vollmar B, Reisinger EC, Sombetzki M: Anatomical MRI and [18 F] FDG PET/CT imaging of Schistosoma mansoni in a NMRI mouse model. Scientific Reports 2020, 10(1):1-11.
  253. Little P: Penumbra oxygen metabolism and acute neuroinflammation in ischemic stroke: MRI and PET imaging of a M2 occlusion model in rat. 2020.
  254. Liu R, Umbach DM, Tröster AI, Huang X, Chen H: Non-motor symptoms and striatal dopamine transporter binding in early Parkinson’s disease. Parkinsonism & Related Disorders 2020, 72:23-30.
  255. Liu S, Li Y, Fan X, Li K, Xu C, Zhang L, Luo M, Wang L, Li R, Wu J: Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity. Adipocyte 2020, 9(1):170-178.
  256. Lobeek D, Rijpkema M, Terry S, Molkenboer-Kuenen J, Joosten L, van Genugten E, van Engen-van Grunsven A, Kaanders J, Pegge S, Boerman O: Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68 Ga] Ga-DOTA-E-[c (RGDfK)] 2 PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-9.
  257. Lohmann P, Elahmadawy MA, Gutsche R, Werner J-M, Bauer EK, Ceccon G, Kocher M, Lerche CW, Rapp M, Fink GR: FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation. Cancers 2020, 12(12):3835.
  258. London ED, Okita K, Kinney KR, Dean AC, McClintick MN, Rizor EJ, Johnson MC, Mahmoudie T, Brody AL, Nurmi EL: No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users. Drug and Alcohol Dependence 2020:108104.
  259. Lu J, Bao W, Li M, Li L, Zhang Z, Alberts I, Brendel M, Cumming P, Lu H, Xiao Z: Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism. Frontiers in neuroscience 2020, 14:604.
  260. Lu J, Bao W, Li M, Li L, Zhang Z, Song J, Alberts I, Brendel M, Cumming P, Zuo C: Study of Tau Deposition in Patients of Alzheimer’s Disease with [18F]-APN-1607 PET tracer and Its Relationship with Cerebral Glucose Metabolism. Journal of Nuclear Medicine 2020, 61(supplement 1):1549-1549.
  261. Lu S, Haskali MB, Ruley KM, Dreyfus NJ-F, DuBois SL, Paul S, Liow J-S, Morse CL, Kowalski A, Gladding RL: PET ligands [18F] LSN3316612 and [11C] LSN3316612 quantify O-linked-β-N-acetyl-glucosamine hydrolase in the brain. Science Translational Medicine 2020, 12(543).
  262. Lubberink M, Eriksson O: [11C] 5-Hydroxy-tryptophan model for quantitative assessment of in vivo serotonin biosynthesis, retention and degradation in the endocrine pancreas. American Journal of Nuclear Medicine and Molecular Imaging 2020, 10(5):226.
  263. Lukas M, Kluge A, Beindorff N, Brenner W: Multi-Isotope Capabilities of a Small-Animal Multi-Pinhole SPECT System. Journal of Nuclear Medicine 2020, 61(1):152-161.
  264. Lundsten S, Spiegelberg D, Raval NR, Nestor M: The radiosensitizer Onalespib increases complete remission in 177 Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
  265. MacAskill MG, McDougald W, Alcaide-Corral C, Newby DE, Tavares AA, Hadoke PW, Wu J: Characterisation of an atherosclerotic micro-calcification model using ApoE−/− mice and PET/CT. International Journal of cardiology Heart & Vasculature 2020, 31.
  266. MacAskill MG, Stadulyte A, Williams L, Morgan TE, Sloan NL, Alcaide-Corral CJ, Walton T, Wimberley C, McKenzie C-A, Spath NB: Quantification of macrophage-driven inflammation during myocardial infarction with 18F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism. Journal of Nuclear Medicine 2020:jnumed. 120.243600.
  267. Mahmud FJ, Du Y, Greif E, Boucher T, Dannals RF, Mathews WB, Pomper MG, Sysa-Shah P, Pate KAM, Lyons C: Osteopontin/Secreted Phosphoprotein-1 Behaves as a Molecular Brake Regulating the Brain Translocator Protein-Dependent Neuroinflammatory Response to Chronic Viral Infection. 2020.
  268. Mahmud FJ, Du Y, Greif E, Boucher T, Dannals RF, Mathews WB, Pomper MG, Sysa-Shah P, Pate KAM, Lyons C: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection. Journal of neuroinflammation 2020, 17(1):1-16.
  269. Malbert CH, Chauvin A, Horowitz M, Jones KL: Pancreatic GLP-1r binding potential is reduced in insulin-resistant pigs. BMJ Open Diabetes Res Care 2020, 8(2).
  270. Malbert CH, Chauvin A, Horowitz M, Jones KL: Glucose Sensing Mediated by Portal Glucagon-Like Peptide 1 Receptor Is Markedly Impaired in Insulin-Resistant Obese Animals. Diabetes 2021, 70(1):99-110.
  271. Malviya G, Patel R, Salji M, Martinez RS, Repiscak P, Mui E, Champion S, Mrowinska A, Johnson E, AlRasheedi M: 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. EJNMMI research 2020, 10(1):1-10.
  272. Mancebo DG, Becerro AI, Corral A, García-Embid S, Balcerzyk M, García ML, Jesús M, Ocaña M: Design of a nanoprobe for high field magnetic resonance imaging, dual energy X-ray computed tomography and luminescent imaging. Journal of Colloid and Interface Science 2020.
  273. Mandrup CM, Roland CB, Egelund J, Nyberg M, Enevoldsen LH, Kjaer A, Clemmensen A, Christensen AN, Suetta C, Frikke-Schmidt R: Effects of High-Intensity Exercise Training on Adipose Tissue Mass, Glucose Uptake and Protein Content in Pre-and Post-menopausal Women. Frontiers in Sports and Active Living 2020, 2.
  274. Manell E: Refinement of porcine models in diabetes and transplantation research. 2020.
  275. Manza P, Wiers CE, Shokri-Kojori E, Kroll D, Feldman D, Schwandt M, Wang G-J, Tomasi D, Volkow ND: Brain Network Segregation and Glucose Energy Utilization: Relevance for Age-Related Differences in Cognitive Function. Cerebral Cortex 2020, 30(11):5930-5942.
  276. Maredziak M, Bengs S, Portmann A, Haider A, Wijnen WJ, Warnock GI, Etter D, Froehlich S, Fiechter M, Meisel A: Microvascular dysfunction and sympathetic hyperactivity in women with supra-normal left ventricular ejection fraction (snLVEF). European Journal of Nuclear Medicine and Molecular Imaging 2020.
  277. Marie S, Hernández-Lozano I, Breuil L, Saba W, Novell A, Gennisson J-L, Langer O, Truillet C, Tournier N: Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc] mebrofenin Imaging in Rats. Pharmaceutics 2020, 12(6):486.
  278. Masaki Y, Kashiwagi Y, Rokugawa T, Ito M, Iimori H, Abe K: Pharmacological MRI responses of raclopride in rats: The relationship with D2 receptor occupancy and cataleptic behavior. Synapse 2020, 74(12):e22180.
  279. Masuoka T, Tateno A, Sakayori T, Tiger M, Kim W, Moriya H, Ueda S, Arakawa R, Okubo Y: Electroconvulsive Therapy Decreases Striatal Dopamine Transporter Binding in Patients with Depression: A Positron Emission Tomography Study with [18F] FE-PE2I. Psychiatry Research: Neuroimaging 2020:111086.
  280. Matsudaira T, Terada T, Obi T, Yokokura M, Takahashi Y, Ouchi Y: Coexistence of cerebral hypometabolism and neuroinflammation in the thalamo-limbic-brainstem region in young women with functional somatic syndrome. EJNMMI research 2020, 10(1):1-11.
  281. Matsusaka Y, Nakahara T, Takahashi K, Iwabuchi Y, Nakamura S, Jinzaki M: Development of 68 Ga-labeled tin colloids for evaluating phagocytic function of Kupffer cells using preclinical PET imaging. Annals of Nuclear Medicine 2020, 34(11):807-814.
  282. Matsuyama K, Yamamoto Y, Sora I: Effect of Feru‐guard 100M on amyloid‐beta deposition in individuals with mild cognitive impairment. Psychogeriatrics 2020, 20(5):726-736.
  283. McDonald ES, Doot RK, Young AJ, Schubert EK, Tchou J, Pryma DA, Farwell MD, Nayak A, Ziober A, Feldman MD: Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status. Journal of Nuclear Medicine 2020, 61(5):665-670.
  284. McGregor M, Richer K, Ananth M, Thanos PK: The functional networks of a novel environment: Neural activity mapping in awake unrestrained rats using positron emission tomography. Brain and behavior 2020, 10(8):e01646.
  285. McNitt-Gray M, Napel S, Jaggi A, Mattonen S, Hadjiiski L, Muzi M, Goldgof D, Balagurunathan Y, Pierce L, Kinahan P: Standardization in quantitative imaging: a multicenter comparison of radiomic features from different software packages on digital reference objects and patient data sets. Tomography 2020, 6(2):118.
  286. Meabon JS, Cook DG, Yagi M, Terry GE, Cross DJ, Muzi M, Pagulayan KF, Logsdon AF, Schindler AG, Ghai V: Chronic elevation of plasma vascular endothelial growth factor-A (VEGF-A) is associated with a history of blast exposure. Journal of the neurological sciences 2020, 417:117049.
  287. Mehta V, Bouchareb Y, Ramaswamy S, Ahmad A, Wodehouse T, Haroon A: Metabolic Imaging of Pain Matrix Using 18F Fluoro‐deoxyglucose Positron Emission Tomography/Computed Tomography for Patients Undergoing L2 Dorsal Root Ganglion Stimulation for Low Back Pain. Neuromodulation: Technology at the Neural Interface 2020, 23(2):222-233.
  288. Meyer M, Lamare F, Asselineau J, Foubert‐Samier A, Mazère J, Zanotti‐Fregonara P, Rizzo G, Delamarre A, Spampinato U, Rascol O: Brain 5‐HT1A Receptor Binding in Multiple System Atrophy: An [18F]‐MPPF PET Study. Movement Disorders 2020.
  289. Miceli A, Cossu V, Marini C, Castellani P, Raffa S, Donegani MI, Bruno S, Ravera S, Emionite L, Orengo AM: 18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress. International journal of molecular sciences 2020, 21(21):8154.
  290. Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR: Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity. Molecular psychiatry 2020, 25(9):2058-2069.
  291. Michalski K, Laubner K, Stoykow C, Omrane MA, Maecke HR, Seufert J, Goetz C, Meyer PT, Ruf J: Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT. Clinical Nuclear Medicine 2020, 45(7):519-524.
  292. Michalski K, Stoykow C, Bronsert P, Juhasz-Böss I, Meyer PT, Ruf J, Erbes T, Asberger J: Association between gastrin-releasing peptide receptor expression as assessed with [68Ga] Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer. Nuclear Medicine and Biology 2020.
  293. Miederer I, Wiegand V, Bausbacher N, Leukel P, Maus S, Hoffmann MA, Lutz B, Schreckenberger M: Quantification of the Cannabinoid Type 1 Receptor Availability in the Mouse Brain. Frontiers in Neuroanatomy 2020, 14:95.
  294. Mihov Y, Treyer V, Akkus F, Toman E, Milos G, Ametamey SM, Johayem A, Hasler G: Metabotropic glutamate receptor 5 in bulimia nervosa. Scientific reports 2020, 10(1):1-10.
  295. Miyamoto M, Miyamoto T, Saitou J, Sato T: Longitudinal study of striatal aromatic l-amino acid decarboxylase activity in patients with idiopathic rapid eye movement sleep behavior disorder. Sleep Medicine 2020, 68:50-56.
  296. Miyaoka RS, Lehnert AL: Small animal PET: a review of what we have done and where we are going. Physics in Medicine & Biology 2020, 65(24):24TR04.
  297. Miyatake Y, Mishima Y, Tsutsumi R, Otani T, Suemasa N, Masumoto S, Kuroda M, Sakaue H: Assessment of insulin resistance in the skeletal muscle of mice using positron emission tomography/computed tomography imaging. Biochemical and Biophysical Research Communications 2020.
  298. Miyazaki T, Nakajima W, Hatano M, Shibata Y, Kuroki Y, Arisawa T, Serizawa A, Sano A, Kogami S, Yamanoue T: Visualization of AMPA receptors in living human brain with positron emission tomography. Nature medicine 2020, 26(2):281-288.
  299. Mohamed-Ahmed S, Yassin MA, Rashad A, Espedal H, Idris SB, Finne-Wistrand A, Mustafa K, Vindenes H, Fristad I: Comparison of bone regenerative capacity of donor-matched human adipose–derived and bone marrow mesenchymal stem cells. Cell and Tissue Research 2020:1-15.
  300. Mohammed F, He X, Lin Y: An easy-to-use deep-learning model for highly accurate diagnosis of Parkinson’s disease using SPECT images. Computerized Medical Imaging and Graphics 2020, 87:101810.
  301. Moon ES, Elvas F, Vliegen G, De Lombaerde S, Vangestel C, De Bruycker S, Bracke A, Eppard E, Greifenstein L, Klasen B: Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators. 2020.
  302. Moriguchi S, Takahata K, Shimada H, Kubota M, Kitamura S, Kimura Y, Tagai K, Tarumi R, Tabuchi H, Meyer JH et al: Excess tau PET ligand retention in elderly patients with major depressive disorder. Molecular Psychiatry 2020.
  303. Moriya H, Tiger M, Tateno A, Sakayori T, Masuoka T, Kim W, Arakawa R, Okubo Y: Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression. Psychiatry and Clinical Neurosciences 2020.
  304. Mosley M, Torres JB, Allen D, Cornelissen B: Immuno-imaging of ICAM-1 in tumours by SPECT. Nuclear Medicine and Biology 2020.
  305. Mu L, Krämer SD, Warnock GI, Haider A, Bengs S, Cartolano G, Bräm DS, Keller C, Schibli R, Ametamey SM: [11 C] mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [18 F] LMI1195 uptake is NET-independent. EJNMMI research 2020, 10(1):1-12.
  306. Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A: Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study. Journal of Nuclear Medicine 2020, 61(6):911-919.
  307. Nagachinta S, Becker G, Dammicco S, Serrano ME, Leroi N, Bahri MA, Plenevaux A, Lemaire C, Lopez R, Luxen A: Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces 2020, 188:110793.
  308. Nagai Y, Miyakawa N, Takuwa H, Hori Y, Oyama K, Ji B, Takahashi M, Huang X-P, Slocum ST, DiBerto JF: Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys. Nature neuroscience 2020, 23(9):1157-1167.
  309. Nakaoka T, Uetake Y, Kaneko K-i, Niwa T, Ochiai H, Irie S, Suezaki Y, Otsuka N, Hayashinaka E, Wada Y: Practical synthesis of [18F] pitavastatin and evaluation of hepatobiliary transport activity in rats by positron emission tomography. Molecular Pharmaceutics 2020.
  310. Nakashima K, Iikuni S, Okada Y, Watanabe H, Shimizu Y, Nakamoto Y, Ono M: Synthesis and Evaluation of 68Ga-labeled Imidazothiadiazole Sulfonamide Derivatives for PET Imaging of Carbonic Anhydrase-IX. Nuclear Medicine and Biology 2020.
  311. Nascimento Dos Santos S, Zhang Z, Turato M, Chammas R, Lin K, Carvalho I: Synthesis and Evaluation of [18F] FEtLos and [18F] AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors. Molecules (Basel, Switzerland) 2020, 25(8).
  312. Nedelcu J, Reinbach C, Riedler P, Brendel M, Rominger A, Kaye J, Behrangi N, Jiangshan Z, Schmitz C, Kipp M: Laquinimod ameliorates secondary brain inflammation. Neurobiology of disease 2020, 134:104675.
  313. Neth BJ, Mintz A, Whitlow C, Jung Y, Sai KS, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J: Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: A pilot study. Neurobiology of aging 2020, 86:54-63.
  314. Neveu M-A, Beziere N, Daniels R, Bouzin C, Comment A, Schwenck J, Fuchs K, Kneilling M, Pichler BJ, Schmid AM: Lactate Production Precedes Inflammatory Cell Recruitment in Arthritic Ankles: an Imaging Study. Molecular Imaging and Biology 2020.
  315. Nicolas CT, Kaiser RA, Hickey RD, Allen KL, Du Z, VanLith CJ, Guthman RM, Amiot B, Suksanpaisan L, Han B: Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver Failure. Molecular Therapy-Methods & Clinical Development 2020, 18:738-750.
  316. Nikolaus S, Beu M, Wittsack H-J, Müller-Lutz A, Antke C, Hautzel H, Mori Y, Mamlins E, Antoch G, Müller H-W: GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the rat. Reviews in the Neurosciences 2020, 1(ahead-of-print).
  317. Niñerola-Baizán A, Aguiar P, Cabrera-Martín M, Vigil C, Gómez-Grande A, Lorenzo C, Rubí S, Sopena P, Camacho V: Relevancia de la cuantificación en los estudios PET cerebrales con 18F-FDG. Revista Española de Medicina Nuclear e Imagen Molecular 2020.
  318. Nishibe H, Tateno A, Sakayori T, Yamamoto M, Kim W, Kakuyama H, Okubo Y: Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia. International Journal of Neuropsychopharmacology 2020.
  319. Niu N, Xing H, Wang X, Ding J, Hao Z, Ren C, Ba J, Zheng L, Fu C, Zhao H: Comparative [18F] FDG and [18F] DPA714 PET imaging and time-dependent changes of brown adipose tissue in tumor-bearing mice. Adipocyte 2020, 9(1):542-549.
  320. Nomura S, Takahashi M, Kato AH, Wada Y, Watanabe Y, Yamashita F, Mukai H: Biosorption-based 64Cu-labeling of bacteria for pharmacokinetic positron-emission tomography. International Journal of Pharmaceutics 2020, 590:119950.
  321. Novy Z, Lobaz V, Vlk M, Kozempel J, Stepanek P, Popper M, Vrbkova J, Hajduch M, Hruby M, Petrik M: Head-To-Head Comparison of Biological Behavior of Biocompatible Polymers Poly (Ethylene Oxide), Poly (2-Ethyl-2-Oxazoline) and Poly [N-(2-Hydroxypropyl) Methacrylamide] as Coating Materials for Hydroxyapatite Nanoparticles in Animal Solid Tumor Model. Nanomaterials 2020, 10(9):1690.
  322. Nugent S, Croteau E, Potvin O, Castellano C-A, Dieumegarde L, Cunnane SC, Duchesne S: Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer’s disease. Scientific Reports 2020, 10(1):1-8.
  323. Núñez Álvarez NO, Cussó F, Cantelar E, Martín Gracia B, Martínez de la Fuente J, Corral Sousa A, Balcerzyk M, Ocaña Jurado M: Bimodal Nd-Doped LuVO4 Nanoprobes Functionalized with Polyacrilic Acid for X-Ray Computed Tomography and NIR Luminescent Imaging. 2020.
  324. Nuñez NO, Cussó F, Cantelar E, Martin-Gracia B, de la Fuente JM, Corral A, Balcerzyk M, Ocaña M: Bimodal Nd-Doped LuVO4 Nanoprobes Functionalized with Polyacrilic Acid for X-Ray Computed Tomography and NIR Luminescent Imaging. Nanomaterials 2020, 10(1):149.
  325. O’Farrell AC, Jarzabek MA, Lindner AU, Carberry S, Conroy E, Miller IS, Connor K, Shiels L, Zanella ER, Lucantoni F: Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models. Cancers 2020, 12(10):2978.
  326. O’Neill E, Kersemans V, Allen PD, Terry SY, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA: Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy. Journal of Nuclear Medicine 2020, 61(5):743-750.
  327. Obokata N, Seki C, Hirata T, Maeda J, Ishii H, Nagai Y, Matsumura T, Takakuwa M, Fukuda H, Minamimoto T: Synthesis and preclinical evaluation of [11C] MTP38 as a novel PET ligand for phophodiesterase 7 in the brain. bioRxiv 2020.
  328. Ogata A, Kimura Y, Ikenuma H, Yamada T, Abe J, Koyama H, Suzuki M, Ichise M, Kato T, Ito K: Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents. Nuclear Medicine and Biology 2020.
  329. Oh SJ, Ahn H, Jung K-H, Han SJ, Nam KR, Kang KJ, Park J-A, Lee KC, Lee YJ, Choi JY: Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson’s Animal Model. Molecular Imaging and Biology 2020:1-12.
  330. Oh SJ, Lee H-J, Jeong YJ, Nam KR, Kang KJ, Han SJ, Lee KC, Lee YJ, Choi JY: evaluation of the neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging. Scientific Reports 2020, 10(1):1-9.
  331. Okazawa H, Ikawa M, Tsujikawa T, Makino A, Mori T, Kiyono Y, Kosaka H: Noninvasive Measurement of [11C] PiB Distribution Volume Using Integrated PET/MRI. Diagnostics 2020, 10(12):993.
  332. Ono M, Takahashi M, Shimozawa A, Fujinaga M, Mori W, Nagai Y, Mimura K, Minamihisamatsu T, Uchida S, Shimojo M: In vivo visualization of propagating α-synuclein pathologies in mouse and marmoset models by a bimodal imaging probe, C05-05. bioRxiv 2020.
  333. Ordonez AA, Wang H, Magombedze G, Ruiz-Bedoya CA, Srivastava S, Chen A, Tucker EW, Urbanowski ME, Pieterse L, Cardozo EF: Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions. Nature medicine 2020, 26(4):529-534.
  334. Ote K, Hashimoto F, Kakimoto A, Isobe T, Inubushi T, Ota R, Tokui A, Saito A, Moriya T, Omura T: Kinetics-Induced Block Matching and 5-D Transform Domain Filtering for Dynamic PET Image Denoising. IEEE Transactions on Radiation and Plasma Medical Sciences 2020, 4(6):720-728.
  335. Ott J, Spilhaug MM, Maschauer S, Rafique W, Jakobsson JE, Hartvig K, Hübner H, Gmeiner P, Prante O, Riss PJ: Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with 18F-Labeled Derivatives in Rats. Journal of medicinal chemistry 2020, 63(17):9484-9499.
  336. Owen J, Thomas E, Menon J, Gray M, Skaripa-Koukelli I, Gill MR, Wallington S, Miller RL, Vallis KA, Carlisle R: Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. Journal of Controlled Release 2020, 319:222-233.
  337. Pak K, Seo S, Kim K, Lee MJ, Shin MJ, Suh S, Im HJ, Park JJ, Kim SJ, Kim IJ: Striatal dopamine transporter changes after glucose loading in humans. Diabetes, Obesity and Metabolism 2020, 22(1):116-122.
  338. Palomar-Bonet M, Atienza M, Cantero JL: Blood total antioxidant status is associated with cortical glucose uptake and factors related to accelerated aging. Brain Structure and Function 2020, 225(2):841-851.
  339. Pan Y-R, Wu C-E, Chen M-H, Huang W-K, Shih H-J, Lan K-L, Yeh C-N: Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model. Vaccines 2020, 8(4):703.
  340. Pannell M, Economopoulos V, Wilson TC, Kersemans V, Isenegger PG, Larkin JR, Smart S, Gilchrist S, Gouverneur V, Sibson NR: Imaging of translocator protein upregulation is selective for pro‐inflammatory polarized astrocytes and microglia. Glia 2020, 68(2):280-297.
  341. Parente A, Maciel ES, JO Dierckx RA, Langendijk JA, de Vries EF, Doorduin J: Delayed effects of a single-dose whole-brain radiation therapy on glucose metabolism and myelin density: a longitudinal PET study. International Journal of Radiation Biology 2020, 96(9):1135-1143.
  342. Park B-N, Kim J-H, Lim TS, Park SH, Kim T-G, Yoon BS, Son KS, Yoon J-K, An Y-S: Therapeutic effect of mesenchymal stem cells in an animal model of Alzheimer’s disease evaluated by β-amyloid positron emission tomography imaging. Australian & New Zealand Journal of Psychiatry 2020:0004867420917467.
  343. Park HS, Song YS, Moon BS, Yoo S-E, Lee JM, Chung Y-T, Kim E, Lee BC, Kim SE: Neurorestorative Effects of a Novel Fas-Associated Factor 1 Inhibitor in the MPTP Model: An [18F] FE-PE2I Positron Emission Tomography Analysis Study. Frontiers in Pharmacology 2020, 11:953.
  344. Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu M, Spann B, Román GC, Schulz PE, Karmonik C: Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network. Journal of Nuclear Medicine 2020, 61(2):263-269.
  345. Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G: [18 F] AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68 Ga] Ga-DOTATATE in neuroendocrine tumour patients. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(13):3033-3046.
  346. Pellegrin M, Bouzourène K, Aubert J-F, Bielmann C, Gruetter R, Rosenblatt-Velin N, Poitry-Yamate C, Mazzolai L: Impact of aerobic exercise type on blood flow, muscle energy metabolism, and mitochondrial biogenesis in experimental lower extremity artery disease. Scientific reports 2020, 10(1):1-14.
  347. Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Pfister J, Mair C, Novy Z, Popper M, Hajduch M: 68 Ga-labelled desferrioxamine-B for bacterial infection imaging. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
  348. Petropoulou P-I, Mosialou I, Shikhel S, Hao L, Panitsas K, Bisikirska B, Luo N, Bahna F, Kim J, Carberry P: Lipocalin-2 is an anorexigenic signal in primates. Elife 2020, 9:e58949.
  349. Pfister J, Summer D, Petrik M, Khoylou M, Lichius A, Kaeopookum P, Kochinke L, Orasch T, Haas H, Decristoforo C: Hybrid imaging of Aspergillus fumigatus pulmonary infection with fluorescent, 68Ga-labelled siderophores. Biomolecules 2020, 10(2):168.
  350. Pinterić M, Podgorski II, Hadžija MP, Bujak IT, Dekanić A, Bagarić R, Farkaš V, Sobočanec S, Balog T: Role of Sirt3 in Differential Sex-Related Responses to a High-Fat Diet in Mice. Antioxidants 2020, 9(2):174.
  351. Polinder-Bos HA, Elting JWJ, Aries MJ, García DV, Willemsen AT, van Laar PJ, Kuipers J, Krijnen WP, Slart RH, Luurtsema G: Changes in cerebral oxygenation and cerebral blood flow during hemodialysis–A simultaneous near-infrared spectroscopy and positron emission tomography study. Journal of Cerebral Blood Flow & Metabolism 2020, 40(2):328-340.
  352. Possner M, Buechel RR, Vontobel J, Mikulicic F, Gräni C, Benz DC, Clerc OF, Fuchs TA, Tobler D, Stambach D: Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries. International Journal of Cardiology 2020, 299:110-115.
  353. Potemkin R, Strauch B, Kuwert T, Prante O, Maschauer S: Development of 18F-fluoroglycosylated PSMA-ligands with improved renal clearance behavior. Molecular Pharmaceutics 2020, 17(3):933-943.
  354. Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifirò G, Ceravolo R, Vitali P, Isaias IU: Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus. Movement Disorders 2020.
  355. Puig O, Henriksen OM, Vestergaard MB, Hansen AE, Andersen FL, Ladefoged CN, Rostrup E, Larsson HB, Lindberg U, Law I: Comparison of simultaneous arterial spin labeling MRI and 15O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states. Journal of Cerebral Blood Flow & Metabolism 2020, 40(8):1621-1633.
  356. Purup MM, Knudsen K, Karlsson P, Terkelsen AJ, Borghammer P: Skin Temperature in Parkinson’s Disease Measured by Infrared Thermography. Parkinson’s Disease 2020, 2020.
  357. Pyo A, Kim D-Y, Kim H, Lim D, Kwon SY, Kang S-R, Kim H-S, Bom H-S, Min J-J: Ultrasensitive detection of malignant melanoma using PET molecular imaging probes. Proceedings of the National Academy of Sciences 2020, 117(23):12991-12999.
  358. Quelven I, Monteil J, Sage M, Saidi A, Mounier J, Bayout A, Garrier J, Cogne M, Durand-Panteix S: 212Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study. Journal of Nuclear Medicine 2020, 61(7):1058-1065.
  359. Quevenco FC, van Bergen JM, Treyer V, Studer ST, Kagerer SM, Meyer R, Gietl AF, Kaufmann PA, Nitsch RM, Hock C: Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4. Frontiers in Aging Neuroscience 2020, 12:46.
  360. Quirino TdC, Ortolan LdS, Sercundes MK, Marinho CRF, Turato WM, Epiphanio S: Lung aeration in experimental malaria-associated acute respiratory distress syndrome by SPECT/CT analysis. Plos one 2020, 15(5):e0233864.
  361. Rey-Bretal D, Moscoso A, Gómez-Lado N, Fernández-Ferreiro A, Silva-Rodríguez J, Ruibal Á, Aguiar P: Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats. Molecular Imaging and Biology 2020:1-11.
  362. Rhodes S, Batzdorf A, Sorci O, Peng M, Jankelovits A, Hornyak J, An J, Noël PB, Høilund-Carlsen PF, Alavi A: Assessment of femoral neck bone metabolism using 18F-sodium fluoride PET/CT imaging. Bone 2020:115351.
  363. Rodríguez-Chinchilla T, Quiroga-Varela A, Molinet-Dronda F, Belloso-Iguerategui A, Merino-Galan L, Jimenez-Urbieta H, Gago B, Rodriguez-Oroz MC: [18 F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-11.
  364. Rosa Fois G, Valla C, Jouberton E, Sas N, Billoux T, Auzeloux P, Cachin F, Miot‐Noirault E, Maigne L: Internal dosimetry of [99mTc] NTP15‐5 radiotracer for cartilage imaging in preclinical and clinical models using the GATE Monte Carlo platform. Medical Physics 2020.
  365. Rosar F, Buchholz H-G, Michels S, Hoffmann MA, Piel M, Waldmann CM, Rösch F, Reuss S, Schreckenberger M: Image quality analysis of 44 Sc on two preclinical PET scanners: a comparison to 68 Ga. EJNMMI physics 2020, 7(1):1-17.
  366. Rosestedt M, Velikyan I, Rosenström U, Estrada S, Åberg O, Weis J, Westerlund C, Ingvast S, Korsgren O, Nordeman P: Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Nuclear Medicine and Biology 2020, 93:54-62.
  367. Ruivo E, Elvas F, Adhikari K, Vangestel C, Van Haesendonck G, Lemière F, Staelens S, Stroobants S, Van der Veken P, Wyffels L: Preclinical Evaluation of a Novel 18F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging. ACS omega 2020, 5(9):4449-4456.
  368. Ruiz-Bedoya CA, Ordonez AA, Werner RA, Plyku D, Klunk MH, Leal J, Lesniak WG, Holt DP, Dannals RF, Higuchi T: 11C-PABA as a Novel PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Studies. Journal of Nuclear Medicine 2020:jnumed. 119.239806.
  369. Rusjan P, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveillé A, Capet M, Duvauchelle T, Schwartz JC, Robert P: Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET. British Journal of Pharmacology 2020.
  370. Sachpekidis C, Kopp-Schneider A, Merz M, Jauch A, Raab M-S, Goldschmidt H, Dimitrakopoulou-Strauss A: Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma? Cancers 2020, 12(5):1335.
  371. Sadeghzadeh M, Wenzel B, Gündel D, Deuther-Conrad W, Toussaint M, Moldovan R-P, Fischer S, Ludwig F-A, Teodoro R, Jonnalagadda S: Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging. Molecules 2020, 25(10):2309.
  372. Sahylí Ortega Pijeira M, Sérgio Gonçalves Nunes P, Nascimento dos Santos S, Zhang Z, Pérez Nario A, Araujo Perini E, Miguel Turato W, Rodríguez Riera Z, Chammas R, H Elsinga P: Synthesis and Evaluation of [18F] FEtLos and [18F] AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors. Molecules 2020, 25(8):1872.
  373. Sakayori T, Tateno A, Arakawa R, Kim W-c, Okubo Y: Evaluation of dopamine D 3 receptor occupancy by blonanserin using [11 C]-(+)-PHNO in schizophrenia patients. Psychopharmacology 2020:1-8.
  374. Samimi R, Kamali-Asl A, Geramifar P, van den Hoff J, Rahmim A: Short-duration dynamic FDG PET imaging: Optimization and clinical application. Physica Medica 2020, 80:193-200.
  375. Sanaat A, Arabi H, Mainta I, Garibotto V, Zaidi H: Projection-space implementation of deep learning-guided low-dose brain PET imaging improves performance over implementation in image-space. Journal of Nuclear Medicine 2020:jnumed. 119.239327.
  376. Sánchez Sánchez de Rojas L: Reparación de daño cerebral mediante biomateriales y terapia celular: estudio experimental. 2020.
  377. Sang Z, Wang K, Bai P, Wu A, Shi J, Liu W, Zhu G, Wang Y, Lan Y, Chen Z: Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry 2020:112265.
  378. Sato T, Furuta T, Liu Y, Naka S, Nagamori S, Kanai Y, Watabe T: Individual Dosimetry System for Targeted Alpha Therapy Based on PHITS Coupled with Microdosimetric Kinetic Model. 2020.
  379. Schaffernicht G, Shang Q, Stievenard A, Bötzel K, Dening Y, Kempe R, Toussaint M, Gündel D, Kranz M, Reichmann H: Physiological and pathological changes in the enteric nervous system of rotenone-exposed mice as potential early biomarkers for Parkinson’s disease. bioRxiv 2020.
  380. Schidlitzki A, Bascuñana P, Srivastava PK, Welzel L, Twele F, Töllner K, Käufer C, Gericke B, Feleke R, Meier M: Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy. Neurobiology of Disease 2020, 134:104664.
  381. Schmidt E, Schinke C, Rullmann M, Luthardt J, Becker G-A, Haars S, Stoppe M, Lobsien D, Hoffmann K-T, Sabri O: Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients. Scientific Reports 2020, 10(1):1-9.
  382. Schmidt ME, Janssens L, Moechars D, Rombouts FJ, Timmers M, Barret O, Constantinescu CC, Madonia J, Russell DS, Sandiego CM: Clinical evaluation of [18 F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-10.
  383. Schneider D, Oskamp A, Holschbach M, Neumaier B, Bier D, Bauer A: Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor. Nuclear Medicine and Biology 2020, 82:1-8.
  384. Schröder S, Lai TH, Toussaint M, Kranz M, Chovsepian A, Shang Q, Dukić-Stefanović S, Deuther-Conrad W, Teodoro R, Wenzel B: PET Imaging of the Adenosine A2A Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [18F] FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy. Molecules 2020, 25(7):1633.
  385. Sekine T, Buck A, Delso G, Kemp B, ter Voert EE, Huellner M, Veit-Haibach P, Kaushik S, Wiesinger F, Warnock G: The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases—A simulation study combining multi-center data and ADNI-data. Plos one 2020, 15(6):e0233886.
  386. Serrano ME, Bahri MA, Becker G, Seret A, Germonpré C, Lemaire C, Giacomelli F, Mievis F, Luxen A, Salmon E: Exploring with [18 F] UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular imaging and biology 2020:1-11.
  387. Shah S, Sinharay S, Matsuda K, Schreiber-Stainthorp W, Muthusamy S, Lee D, Wakim P, Hirsch V, Nath A, Di Mascio M: 11C-DASB PET. Identifying Neuroimaging-Based Markers for Distinguishing Brain Disorders 2020.
  388. Shalgunov V, Xiong M, L’Estrade ET, Raval NR, Andersen IV, Edgar FG, Speth NR, Baerentzen SL, Hansen HD, Donovan LL: Blocking of efflux transporters in rats improves translational validation of brain radioligands. EJNMMI research 2020, 10(1):1-11.
  389. Shannon AH, Chordia MD, Spinosa MD, Su G, Ladd Z, Pan D, Upchurch Jr GR, Sharma AK: Single-Photon Emission Computed Tomography Imaging Using Formyl Peptide Receptor 1 Ligand Can Diagnose Aortic Aneurysms in a Mouse Model. journal of surgical research 2020, 251:239-247.
  390. Shiiba T, Arimura Y, Nagano M, Takahashi T, Takaki A: Improvement of classification performance of Parkinson’s disease using shape features for machine learning on dopamine transporter single photon emission computed tomography. PloS one 2020, 15(1):e0228289.
  391. Shimada H, Minatani S, Takeuchi J, Takeda A, Kawabe J, Wada Y, Mawatari A, Watanabe Y, Shimada H, Higuchi M: Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation. International journal of molecular sciences 2020, 21(12):4443.
  392. Shimojo M, Takuwa H, Takado Y, Tokunaga M, Tsukamoto S, Minatohara K, Ono M, Seki C, Maeda J, Urushihata T: Selective disruption of inhibitory synapses leading to neuronal hyperexcitability at an early stage of tau pathogenesis in a mouse model. Journal of Neuroscience 2020, 40(17):3491-3501.
  393. Shimokawa N, Akamatsu G, Kadosaki M, Sasaki M: Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation. Ann Nucl Med 2020, 34(9):629-635.
  394. Shin S, Nam H-Y, Lee MJ, Pak K, Kim K, Kim IJ: Effect of sex on aging-related decline of dopamine transporter in healthy subjects. Annals of Nuclear Medicine 2020:1-7.
  395. Shin U, Kim J, Lee J, Park D, Lee C, Jung HC, Park J, Lee K, Lee MW, Kim SW: Development of 64Cu-loaded Perfluoropentane Nanodroplet: A Potential Tumor Theragnostic Nano-carrier and Dual-Modality PET-Ultrasound Imaging Agents. Ultrasound in Medicine & Biology 2020, 46(10):2775-2784.
  396. Shinotoh H, Hirano S, Shimada H: PETImagingofAcetylcholinesterase 7. PET and SPECT of Neurobiological Systems 2020:193.
  397. Shrestha S, Kim M-J, Eldridge M, Lehmann ML, Frankland M, Liow J-S, Yu Z-X, Cortes-Salva M, Telu S, Henter ID: PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. Journal of Neuroinflammation 2020, 17:1-17.
  398. Shrestha UM, Sciammarella M, Pampaloni MH, Botvinick EH, Gullberg GT, DeMarco T, Seo Y: Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82 Rb PET. The International Journal of Cardiovascular Imaging 2020:1-12.
  399. Singhal T, Cicero S, Pan H, Carter K, Dubey S, Chu R, Glanz B, Hurwitz S, Tauhid S, Park M-A: Regional microglial activation in the substantia nigra is linked with fatigue in MS. Neurology-Neuroimmunology Neuroinflammation 2020, 7(5).
  400. Smith R, Schöll M, Leuzy A, Jögi J, Ohlsson T, Strandberg O, Hansson O: Head-to-head comparison of tau positron emission tomography tracers [18 F] flortaucipir and [18 F] RO948. European journal of nuclear medicine and molecular imaging 2020, 47(2):342-354.
  401. Smyczyńska U, Strzemecki D, Czarnecka AM, Fendler W, Fiedorowicz M, Wełniak-Kamińska M, Guzowska M, Synoradzki K, Cheda Ł, Rogulski Z: TP53-Deficient Angiosarcoma Expression Profiling in Rat Model. Cancers 2020, 12(6):1525.
  402. Snitz BE, Tudorascu DL, Yu Z, Campbell E, Lopresti BJ, Laymon CM, Minhas DS, Nadkarni NK, Aizenstein HJ, Klunk WE: Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12018.
  403. Son Y, Jeong YJ, Shin N-R, Oh SJ, Nam KR, Choi H-D, Choi JY, Lee H-J: Inhibition of colony-stimulating factor 1 Receptor by PLX3397 prevents amyloid beta pathology and rescues dopaminergic signaling in aging 5xFAD mice. International journal of molecular sciences 2020, 21(15):5553.
  404. Souza Vieira S, Antonio EL, de Melo BL, Neves dos Santos LF, Santana ET, Feliciano R, Marques FLN, de Paula Faria D, Buchpiguel CA, Silva JA: Increased Myocardial Retention of Mesenchymal Stem Cells Post-MI by Pre-Conditioning Exercise Training. Stem Cell Reviews and Reports 2020:1-12.
  405. Spath N, Tavares A, Gray GA, Baker AH, Lennen RJ, Alcaide-Corral CJ, Dweck MR, Newby DE, Yang PC, Jansen MA: Manganese-enhanced T 1 mapping to quantify myocardial viability: validation with 18 F-fluorodeoxyglucose positron emission tomography. Scientific Reports 2020, 10(1):1-10.
  406. Squarzoni P, Faria DdP, Yassuda MS, Porto FHdG, Coutinho AM, Costa NAd, Nitrini R, Forlenza OV, Duran FLdS, Brucki SMD: Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects. Journal of Alzheimer’s Disease 2020(Preprint):1-16.
  407. Stær K, Iranzo A, Stokholm MG, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Santamaria J: Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder. Parkinsonism & Related Disorders 2020, 81:89-93.
  408. Stanford D, Kim H, Bodduluri S, LaFontaine J, Byzek SA, Schoeb TR, Harris ES, Nath HP, Bhatt SP, Raju SV: Airway Remodeling in Ferrets with Cigarette Smoke Induced COPD using µCT Imaging. American Journal of Physiology-Lung Cellular and Molecular Physiology 2020.
  409. Staudacher AH, Liapis V, Tieu W, Wittwer NL, Brown MP: Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody. Journal of Controlled Release 2020, 327:779-787.
  410. Stegmayr C, Surges R, Choi C-H, Burda N, Stoffels G, Filß C, Willuweit A, Neumaier B, Heinzel A, Shah NJ: Investigation of Cerebral O-(2-[18 F] Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models. Molecular imaging and biology 2020.
  411. Stojakovic A, Chang S-Y, Nesbitt J, Pichurin NP, Ostroot MA, Aikawa T, Kanekiyo T, Trushina E: Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice. Journal of Alzheimer’s Disease 2020(Preprint):1-19.
  412. Strähl M, Schindler M, Keller LS, Holy E, Jakob P, Siegrist PT, Templin C, Maier W, Buechel RR, Kaufmann PA: Diagnostic performance of angiography-based quantitative flow ratio for the identification of myocardial ischemia as assessed by 13N-ammonia myocardial perfusion imaging positron emission tomography. International Journal of Cardiology 2020.
  413. Stutvoet TS, van der Veen EL, Kol A, Antunes IF, de Vries EF, Hospers GA, de Vries EG, de Jong S, Lub-de Hooge MN: Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer 18F-BMS-986192. Journal of Nuclear Medicine 2020:jnumed. 119.241364.
  414. Sullivan KJ, Liu A, Chang C-CH, Cohen AD, Lopresti BJ, Minhas DS, Laymon CM, Klunk WE, Aizenstein H, Nadkarni NK: Alzheimer’s disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study. Brain Imaging and Behavior 2020:1-9.
  415. Suurs FV, Lorenczewski G, Stienen S, Friedrich M, de Vries EG, De Groot DJA, Lub-de Hooge MN: Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm. Journal of Nuclear Medicine 2020:jnumed. 120.241877.
  416. Švec P, Nový Zk, Kučka J, Petřík M, Sedláček Oe, Kuchař M, Lišková B, Medvedíková M, Kolouchová Kn, Groborz Oe: Iodinated Choline Transport-Targeted Tracers. Journal of Medicinal Chemistry 2020.
  417. Svirydenka H, Muehlematter UJ, Nagel HW, Delso G, Ferraro DA, Kudura K, Burger IA, Ter Voert EE: 68 Ga-PSMA-11 dose reduction for dedicated pelvic imaging with simultaneous PET/MR using TOF BSREM reconstructions. European Radiology 2020:1-10.
  418. Tada T, Ito Y, Murayama R, Tamura M, Tsutsumi Y, Kato K, Ochi Y, Ikeda H: Comparative Study of Various Reference Regions for Standardized Uptake Value Ratio Using11C-Pittsburgh Compound-B PET and MR Images. Journal of Nuclear Medicine 2020, 61(supplement 1):3099-3099.
  419. Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Yamamoto Y: High-contrast in vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathies. Neuron 2020.
  420. Tago T, Toyohara J, Ishii K: Radiosynthesis and preliminary evaluation of an 18F‐labeled tubastatin A analog for PET imaging of histone deacetylase 6. Journal of Labelled Compounds and Radiopharmaceuticals 2020, 63(2):85-95.
  421. Takeuchi H, Imamura K, Ji B, Tsukita K, Enami T, Takao K, Miyakawa T, Hasegawa M, Sahara N, Iwata N: Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice. npj Vaccines 2020, 5(1):1-11.
  422. Talalwa L, Natour G, Bauer A, Drzezga A, Beer S: Radiological characteristics of a new experimental rubber elastomeric polymer used in three-dimensional printing with different infill densities and patterns. Journal of Physics Communications 2020.
  423. Tang J: An approach for the in-vivo characterization of brain and heart inflammation in Duchenne Muscular Dystrophy. 2020.
  424. Terada T, Obi T, Bunai T, Matsudaira T, Yoshikawa E, Ando I, Futatsubashi M, Tsukada H, Ouchi Y: In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology 2020, 94(15):e1592-e1604.
  425. Térence T, Cawthorne C, Kim S, Elin P, Willy G, Guy B, Deroose CM, Frederik C: Automated GMP compliant production of [18 F] AlF-NOTA-octreotide. EJNMMI Radiopharmacy and Chemistry 2020, 5(1).
  426. Thiele S, Sörensen A, Weis J, Braun F, Meyer PT, Coenen VA, Döbrössy MD: Deep Brain Stimulation of the Medial Forebrain Bundle in a Rodent Model of Depression: Exploring Dopaminergic Mechanisms with Raclopride and Micro-PET. Stereotactic and Functional Neurosurgery 2020, 98(1):8-20.
  427. Thomsen MB, Ferreira SA, Schacht AC, Jacobsen J, Simonsen M, Betzer C, Jensen PH, Brooks DJ, Landau AM, Romero-Ramos M: PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease 2020:105229.
  428. Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM: In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C] UCB-J PET. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20931140.
  429. Thomsen MB, Schacht AC, Alstrup AKO, Jacobsen J, Lillethorup TP, Bærentzen SL, Noer O, Orlowski D, Elfving B, Müller HK: Preclinical PET Studies of [11 C] UCB-J Binding in Minipig Brain. Molecular Imaging and Biology 2020.
  430. Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV: The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene 2020, 39(8):1652-1664.
  431. Thorne M, Cash M, Reid G, Burley D, Luke D, Pottie I, Darvesh S: Imaging Butyrylcholinesterase in Multiple Sclerosis. Molecular Imaging and Biology 2020:1-12.
  432. Tiepolt S, Becker G-A, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J: (+)-[18 F] Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls. European Journal of Nuclear Medicine and Molecular Imaging 2020:1-16.
  433. Tiepolt S, Rullmann M, Jochimsen TH, Gertz H-J, Schroeter ML, Patt M, Sabri O, Barthel H: Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls–A hybrid PET/MRI study. European Journal of Radiology 2020, 131:109243.
  434. Tiwari AK, Zhang Y, Yamasaki T, Kumari N, Fujinaga M, Mori W, Hatori A, Nengaki N, Mishra AK, Zhang H: Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [11C] N′-MPB for visualization of 18 kDa TSPO in brain. New Journal of Chemistry 2020, 44(19):7912-7922.
  435. Tjerkaski J, Cervenka S, Farde L, Matheson GJ: Kinfitr–an open source tool for reproducible PET modelling: validation and evaluation of test-retest reliability. BioRxiv 2020.
  436. Tjörnstrand A: Pituitary Tumors-Epidemiology and the Diagnostic Value of 68Ga-DOTATOC PET. 2020.
  437. Tjörnstrand A, Casar‐Borota O, Heurling K, Schöll M, Gjertsson P, Himmelman J, Itsenko O, Ragnarsson O, Filipsson Nyström H: Lower 68Ga‐DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland—A proof‐of‐concept study. Clinical Endocrinology 2020, 92(3):222-231.
  438. Tobey H, Lucas T, Paul S, Berr SS, Mehrkens B, Brolinson PG, Klein BG, Costa BM: Mechanoceutics Alters Alzheimer’s Disease Phenotypes in Transgenic Rats: A Pilot Study. Journal of Alzheimer’s Disease 2020(Preprint):1-7.
  439. Toledano M, Gutierrez-Pérez JL, Gutierrez-Corrales A, Serrera-Figallo MA, Toledano-Osorio M, Rosales-Leal JI, Aguilar M, Osorio R, Torres-Lagares D: Novel non-resorbable polymeric-nanostructured scaffolds for guided bone regeneration. Clinical oral investigations 2020, 24(6):2037-2049.
  440. Toledano M, Toledano-Osorio M, Osorio R, Carrasco-Carmona Á, Gutiérrez-Pérez J-L, Gutiérrez-Corrales A, Serrera-Figallo M-A, Lynch CD, Torres-Lagares D: Doxycycline and Zinc Loaded Silica-Nanofibrous Polymers as Biomaterials for Bone Regeneration. Polymers 2020, 12(5):1201.
  441. Toms J, Kogler J, Maschauer S, Daniel C, Schmidkonz C, Kuwert T, Prante O: Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-labeled FAP Inhibitor. Journal of Nuclear Medicine 2020:jnumed. 120.242958.
  442. Toramatsu C, Mohammadi A, Wakizaka H, Seki C, Nishikido F, Sato S, Kanno I, Takahashi M, Karasawa K, Hirano Y: Biological washout modelling for in-beam PET: rabbit brain irradiation by 11C and 15O ion beams. Physics in Medicine & Biology 2020, 65(10):105011.
  443. Torres JB, Mosley M, Koustoulidou S, Hopkins S, Knapp S, Chaikuad A, Kondoh M, Tachibana K, Kersemans V, Cornelissen B: Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer. Journal of Nuclear Medicine 2020:jnumed. 120.243113.
  444. Tournier BB, Tsartsalis S, Ceyzériat K, Medina Z, Fraser BH, Grégoire M-C, Kövari E, Millet P: Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. Journal of Cerebral Blood Flow & Metabolism 2020, 40(6):1242-1255.
  445. Tournier N, Goutal S, Mairinger S, Hernández-Lozano I, Filip T, Sauberer M, Caillé F, Breuil L, Stanek J, Freeman AF: Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C] erlotinib. Journal of Cerebral Blood Flow & Metabolism 2020:0271678X20965500.
  446. Tournier N, Pottier G, Caillé F, Coulon C, Goislard M, Jégo B, Negroni J, Leroy C, Saba W: Nalmefene alleviates the neuroimmune response to repeated binge‐like ethanol exposure: A TSPO PET imaging study in adolescent rats. Addiction Biology 2020:e12962.
  447. Toussaint M, Deuther-Conrad W, Kranz M, Fischer S, Ludwig F-A, Juratli TA, Patt M, Wünsch B, Schackert G, Sabri O: Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[18F] Fluspidine in Glioblastoma. Molecules 2020, 25(9):2170.
  448. Toyohara J, Harada N, Kakiuchi T, Ohba H, Kanazawa M, Tago T, Sakata M, Ishiwata K: Synthesis and evaluation of N-isopropyl-p-[11 C] methylamphetamine as a novel cerebral blood flow tracer for positron emission tomography. EJNMMI research 2020, 10(1):1-13.
  449. Tran T, Esposito B, Montabord M, Rajau JT, Gruel N, Lenoir O, Ait-Oufella H, Stockmann C, Mallat Z, Tedgui A: Pro-atherogenic diet accelerates tumor growth in mice through IL-1β and myeloid cell-derived VEGF-A. 2020.
  450. Tsai C-N, Yu S-C, Lee C-W, Pang J-HS, Wu C-H, Lin S-E, Chung Y-H, Tsai C-L, Hsieh S-Y, Yu M-C: SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo. Oncogene 2020:1-16.
  451. Tsartsalis S, Tournier BB, Millet P: In vivo absolute quantification of striatal and extrastriatal D 2/3 receptors with [123 I] epidepride SPECT. EJNMMI research 2020, 10(1):1-14.
  452. Tshibangu T, Cawthorne C, Serdons K, Pauwels E, Gsell W, Bormans G, Deroose CM, Cleeren F: Automated GMP compliant production of [18 F] AlF-NOTA-octreotide. EJNMMI radiopharmacy and chemistry 2020, 5(1):4.
  453. Tu T-W, Kovacs ZI, Sundby M, Witko JA, Papadakis GZ, Reid WC, Hammoud DA, Frank JA: Diffusion Tensor Imaging and Chemical Exchange Saturation Transfer MRI Evaluation on the Long-Term Effects of Pulsed Focused Ultrasound and Microbubbles Blood Brain Barrier Opening in the Rat. Frontiers in neuroscience 2020, 14:908.
  454. Van Camp N, Balbastre Y, Herard A-S, Lavisse S, Tauber C, Wimberley C, Guillermier M, Berniard A, Gipchtein P, Jan C: Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate. Journal of Cerebral Blood Flow & Metabolism 2020, 40(5):1103-1116.
  455. van der Veen EL, Giesen D, Pot-de Jong L, Jorritsma-Smit A, De Vries EG, Lub-de Hooge MN: 89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs. Journal for immunotherapy of cancer 2020, 8(2).
  456. van der Veen EL, Suurs FV, Cleeren F, Bormans G, Elsinga PH, Hospers GA, Lub-de Hooge MN, de Vries EG, de Vries EF, Antunes IF: Development and evaluation of interleukin-2 derived radiotracers for PET imaging of T-cells in mice. Journal of Nuclear Medicine 2020:jnumed. 119.238782.
  457. van der Weide H, Cossío U, Gracia R, Te Welscher YM, Marian T, van der Meijden A, Marradi M, Ritsema JA, Vermeulen-de Jongh DM, Storm G: Therapeutic efficacy of novel antimicrobial peptide AA139-nanomedicines in a multidrug-resistant Klebsiella pneumoniae pneumonia-septicemia model in rats. Antimicrobial Agents and Chemotherapy 2020, 64(9).
  458. van Duin ED, Ceccarini J, Booij J, Kasanova Z, Vingerhoets C, van Huijstee J, Heinzel A, Mohammadkhani-Shali S, Winz O, Mottaghy F: Lower [18 F] fallypride binding to dopamine D 2/3 receptors in frontal brain areas in adults with 22q11. 2 deletion syndrome: a positron emission tomography study. Psychological medicine 2020, 50(5):799-807.
  459. Van Weehaeghe D, Babu S, De Vocht J, Zürcher NR, Chew S, Tseng C-EJ, Loggia ML, Koole M, Rezaei A, Schramm G: Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands. Journal of Nuclear Medicine 2020, 61(11):1621-1627.
  460. Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, Declercq L, Thal DR, Van Damme P, Bormans G: TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study. Journal of Nuclear Medicine 2020, 61(4):604-607.
  461. Vandergaast R, Khongwichit S, Jiang H, DeGrado TR, Peng K-W, Smith DR, Russell SJ, Suksanpaisan L: Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging. Cancer Gene Therapy 2020, 27(3):179-188.
  462. Vanhaute H, Ceccarini J, Michiels L, Koole M, Sunaert S, Lemmens R, Triau E, Emsell L, Vandenbulcke M, Van Laere K: In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment. Neurology 2020.
  463. Varnäs K, Finnema SJ, Johnström P, Arakawa R, Halldin C, Eriksson LI, Farde L: Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo. British Journal of Anaesthesia 2020.
  464. Vega SC, Leiss V, Piekorz R, Calaminus C, Pexa K, Vuozzo M, Schmid AM, Devanathan V, Kesenheimer C, Pichler BJ: Selective protection of murine cerebral G i/o-proteins from inactivation by parenterally injected pertussis toxin. Journal of Molecular Medicine 2020, 98(1):97-110.
  465. Velikyan I, Doverfjord JG, Estrada S, Steen H, Van Scharrenburg G, Antoni G: GMP production of [68Ga] Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study. Nuclear Medicine and Biology 2020, 88:73-85.
  466. Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, Raedt R, Vanhove C, De Vos F, Goethals I: 2-[18F] FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. Nuclear Medicine and Biology 2020, 82:9-16.
  467. Vetel S, Vercouillie J, Buron F, Vergote J, Tauber C, Busson J, Chicheri G, Routier S, Sérrière S, Chalon S: Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18 F] ASEM in a Rat Model of Parkinson’s Disease. Molecular Imaging and Biology 2020, 22(2):348-357.
  468. Vignal N, Boulay A-C, San C, Cohen-Salmon M, Rizzo-Padoin N, Sarda-Mantel L, Declèves X, Cisternino S, Hosten B: Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [18F] FEPPA. Cells 2020, 9(2):389.
  469. Vigne J, Cabella C, Dézsi L, Rustique E, Couffin A-C, Aid R, Anizan N, Chauvierre C, Letourneur D, Le Guludec D: Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE−/− mice. Nanomedicine: Nanotechnology, Biology and Medicine 2020, 25:102157.
  470. Viswanath V, Pantel AR, Daube-Witherspoon ME, Doot R, Muzi M, Mankoff DA, Karp JS: Quantifying bias and precision of kinetic parameter estimation on the PennPET Explorer, a long axial field-of-view scanner. IEEE Transactions on Radiation and Plasma Medical Sciences 2020, 4(6):735-749.
  471. Viswanath V, Zhou R, Lee H, Li S, Cragin A, Doot RK, Mankoff DA, Pantel AR: Kinetic Modeling of 18F-(2S, 4R) 4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism. Journal of Nuclear Medicine 2020:jnumed. 120.250977.
  472. Vrist MH, Bech JN, Lauridsen TG, Fynbo CA, Theil J: Validation and Comparison of [18F] NaF PET/CT Analysis Methods and Derivation of a Semi-population Input Function for Site Specific Measurements of Bone Formation in a Population with Chronic Kidney Disease Mineral and Bone Disorder. 2020.
  473. Wakabayashi Y, Telu S, Dick RM, Fujita M, Ooms M, Morse CL, Liow J-S, Hong JS, Gladding RL, Manly LS: Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D. ACS Chemical Neuroscience 2020, 11(9):1311-1323.
  474. Wanek T, Zoufal V, Brackhan M, Krohn M, Mairinger S, Filip T, Sauberer M, Stanek J, Pekar T, Pahnke J: Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model. International Journal of Molecular Sciences 2020, 21(21):8245.
  475. Wang F, Wang Z, Wang F, Dong K, Zhang J, Sun Y-J, Liu C-F, Xing M-J, Cheng X, Wei S: Comparative strategies for stem cell biodistribution in a preclinical study. Acta Pharmacologica Sinica 2020, 41(4):572-580.
  476. Wang PN, Lin KJ, Liu HC, Andreasson U, Blennow K, Zetterberg H, Yang SY: Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020, 12(1):e12029.
  477. Wani M, Jagdale S, Khanna P, Gholap R, Baheti A: Formulation and Evaluation of Ophthalmic In-Situ Gel using Moxifloxacin Coated Silver Nanoparticles. Research Journal of Pharmacy and Technology 2020, 13(8):3623-3630.
  478. Weerasekera A, Crabbé M, Tomé SO, Gsell W, Sima D, Casteels C, Dresselaers T, Deroose C, Van Huffel S, Thal DR: Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: A PET-MR study. NeuroImage: Clinical 2020, 27:102327.
  479. Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM: On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D 2/3 receptor agonist radioligand study. Translational psychiatry 2020, 10(1):1-11.
  480. Weng C-C, Hsiao I-T, Yang Q-F, Yao C-H, Tai C-Y, Wu M-F, Yen T-C, Jang M-K, Lin K-J: Characterization of 18F-PM-PBB3 (18F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy. Molecules 2020, 25(7):1750.
  481. Werner G, Damme M, Schludi M, Gnörich J, Wind K, Fellerer K, Wefers B, Wurst W, Edbauer D, Brendel M: Loss of TMEM 106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice. EMBO reports 2020, 21(10):e50241.
  482. Workman CD, Fietsam AC, Ponto LLB, Kamholz J, Rudroff T: Individual Cerebral Blood Flow Responses to Transcranial Direct Current Stimulation at Various Intensities. Brain sciences 2020, 10(11):855.
  483. Workman CD, Kindred JH, Boles Ponto LL, Kamholz J, Rudroff T: The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study. Applied Physiology, Nutrition, and Metabolism 2020, 45(4):450-452.
  484. Workman CD, Ponto LLB, Kamholz J, Rudroff T: No immediate effects of transcranial direct current stimulation at various intensities on cerebral blood flow in people with multiple sclerosis. Brain Sciences 2020, 10(2):82.
  485. Xu H, Jiang S, Wang J, Li X, Wu T, Xu P, Santos-Oliveira R, Zhang A: Radioactive Gold Nanoparticle in Two Forms (198 79Au GNPs and 99mTc-GNPs) for Lung Cancer Antiproliferative Induction and Intralesional Imaging: A Proof of Concept. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2020, 20(14):1648-1653.
  486. Xu Y, Wang C, Wey H-Y, Liang Y, Chen Z, Choi SH, Ran C, Rynearson KD, Bernales DR, Koegel RE: Molecular imaging of Alzheimer’s disease–related gamma-secretase in mice and nonhuman primates. Journal of Experimental Medicine 2020, 217(12).
  487. Xue Y, Liu X, Koundal S, Constantinou S, Dai F, Santambrogio L, Lee H, Benveniste H: In vivo T1 mapping for quantifying glymphatic system transport and cervical lymph node drainage. Scientific reports 2020, 10(1):1-13.
  488. Yamagishi S, Iga Y, Ikegaya S, Kakiuchi T, Ohba H, Nishiyama S, Kanazawa M, Tsukada H, Sato K, Ouchi Y: In Vivo Elevation of Mitochondrial Activity and Amyloid Deposition, but Inversely Correlated, in Early-stage Senescence-Accelerated Mice: A Positron Emission Tomography Study. 2020.
  489. Yamamoto Y, Takahata K, Kubota M, Takano H, Takeuchi H, Kimura Y, Sano Y, Kurose S, Ito H, Mimura M: Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain. NeuroImage 2020, 226:117543.
  490. Yan S, Zheng C, Paranjpe MD, Li J, Benzinger TL, Lu J, Zhou Y: Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer’s disease. Theranostics 2020, 10(23):10563.
  491. Yang K-C, Yang B-H, Lirng J-F, Liu M-N, Hu L-Y, Liou Y-J, Chan L-A, Chou Y-H: Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: A combined SPECT and MRS study. Neurotoxicology 2020, 82:26-34.
  492. Yang Y-J, Bu L-L, Shen C, Ge J-J, He S-J, Yu H-L, Tang Y-L, Jue Z, Sun Y-M, Yu W-B: Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson’s Disease by Autophagy Activation. Journal of Parkinson’s disease 2020(Preprint):1-11.
  493. Yeh CI, Cheng MF, Xiao F, Chen YC, Liu CC, Chen HY, Yen RF, Ju YT, Chen Y, Bodduluri M: Effects of Focal Radiation on [18F]‐Fluoro‐D‐Glucose Positron Emission Tomography in the Brains of Miniature Pigs: Preliminary Findings on Local Metabolism. Neuromodulation: Technology at the Neural Interface 2020.
  494. Yeh SH-H, Shie F-S, Liu H-K, Yao H-H, Kao P-C, Lee Y-H, Chen L-M, Hsu S-M, Chao L-J, Wu K-W: A high-sucrose diet aggravates Alzheimer’s disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice. Neurobiology of aging 2020, 90:60-74.
  495. Yoan M, Valerie T, Funda A, Toman E, Gabriella M, Anass J, Hasler G: Metabotropic glutamate receptor 5 in bulimia nervosa. Scientific Reports (Nature Publisher Group) 2020, 10(1).
  496. Yokokura M, Takebasashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y: In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study. Molecular Psychiatry 2020:1-10.
  497. Yoon J-K, Byeon HE, Ko SA, Park B-N, An Y-S, Lee H-Y, Lee YW, Lee SJ: cell cycle synchronisation using thiazolidinediones affects cellular glucose metabolism and enhances the therapeutic effect of 2-deoxyglucose in colon cancer. Scientific reports 2020, 10(1):1-7.
  498. Yoshimura Y, Kikuchi M, Saito DN, Hirosawa T, Takahashi T, Munesue T, Kosaka H, Naito N, Ouchi Y, Minabe Y: Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder. Scientific Reports 2020, 10(1):1-10.
  499. Yuan G, Qu X, Zheng B, Neelamegam R, Afshar S, Iyengar S, Pan C, Wang J, Kang HJ, Ondrechen MJ: Design, Synthesis, and Characterization of Benzimidazole Derivatives as Positron Emission Tomography Imaging Ligands for Metabotropic Glutamate Receptor 2. Journal of Medicinal Chemistry 2020, 63(20):12060-12072.
  500. Zaer H, Glud AN, Schneider BM, Lukacova S, Hansen KV, Adler JR, Høyer M, Jensen MB, Hansen R, Hoffmann L: Radionecrosis and cellular changes in small volume stereotactic brain radiosurgery in a porcine model. Scientific Reports 2020, 10(1):1-12.
  501. Zaibaq NG, Pollard AC, Collins MJ, Pisaneschi F, Pagel MD, Wilson LJ: Evaluation of the Biodistribution of Serinolamide-Derivatized C60 Fullerene. Nanomaterials 2020, 10(1):143.
  502. Zech J, Mader M, Gündel D, Metz H, Odparlik A, Agarwal S, Mäder K, Greiner A: Noninvasive characterization (EPR, μCT, NMR) of 3D PLA electrospun fiber sponges for controlled drug delivery. International journal of pharmaceutics: X 2020, 2:100055.
  503. Zhang Y, García-Gabilondo M, Grayston A, Feiner IV, Anton-Sales I, Loiola RA, Llop J, Ramos-Cabrer P, Barba I, Garcia-Dorado D: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities. Nanoscale 2020, 12(8):4988-5002.
  504. Zhao J, Wen X, Li T, Shi S, Xiong C, Wang YA, Li C: Concurrent Injection of Unlabeled Antibodies Allows Positron Emission Tomography Imaging of Programmed Cell Death Ligand 1 Expression in an Orthotopic Pancreatic Tumor Model. ACS omega 2020, 5(15):8474-8482.
  505. Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM: Progressive brain atrophy in Parkinson’s disease patients who convert to mild cognitive impairment. CNS neuroscience & therapeutics 2020, 26(1):117-125.
  506. Zhu P, Wu M, Ma B, Wang S: Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine. Experimental and Therapeutic Medicine 2020, 21(1):1-1.
  507. Zou J, Tao S, Johnson A, Tomljanovic Z, Polly K, Klein J, Razlighi QR, Brickman AM, Lee S, Stern Y: Microglial activation, but not tau pathology, is independently associated with amyloid positivity and memory impairment. Neurobiology of aging 2020, 85:11-21.
  508. Zoufal V, Mairinger S, Brackhan M, Krohn M, Filip T, Sauberer M, Stanek J, Wanek T, Tournier N, Bauer M: Imaging P-Glycoprotein Induction at the Blood–Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET. Journal of Nuclear Medicine 2020, 61(7):1050-1057.
  509. Zoufal V, Mairinger S, Krohn M, Wanek T, Filip T, Sauberer M, Stanek J, Kuntner C, Pahnke J, Langer O: Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2020, 40(5):954-965.
  510. Zoufal V, Wanek T, Krohn M, Mairinger S, Filip T, Sauberer M, Stanek J, Pekar T, Bauer M, Pahnke J: Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET. Journal of Cerebral Blood Flow & Metabolism 2020, 40(1):150-162.
  511. Zürcher N, Loggia M, Mullett J, Tseng C, Bhanot A, Richey L, Hightower B, Wu C, Parmar A, Butterfield R: [11 C] PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder. Molecular Psychiatry 2020:1-11.